UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

(Mark One)

|X|   QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES  EXCHANGE ACT
      OF 1934

                  For the quarterly period ended June 30, 2006

|_|   TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

              For the transition period from________ to ___________

                         Commission File No. 333-105840

                         MEDICAL MEDIA TELEVISION, INC.
        (Exact Name of Small Business Issuer as Specified in Its Charter)

<TABLE>
<S>                                                                             <C>
                  Florida                                                                  59-3645932
                  -------                                                                  ----------
(State or Other Jurisdiction of Incorporation or Organization)                  (I.R.S. Employer Identification No.)
</TABLE>

                           8406 Benjamin Road, Suite C
                              Tampa, Florida 33634
                              --------------------
                    (Address of Principal Executive Offices)

                                 (813) 888-7330
                                 --------------
                           (Issuer's Telephone Number)

--------------------------------------------------------------------------------
              (Former Name, Former Address and Former Fiscal Year,
                         if Changed Since Last Report)

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days.
                                 Yes |X| No |_|

Indicate by check mark whether the  registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act).
                                 Yes |_| No |X|

The number of shares  outstanding of the Registrant's  common stock as of August
11, 2006 was 21,117,136.

Transitional Small Business Disclosure Format:
                                 Yes |_| No |X|

<PAGE>

PART I - FINANCIAL INFORMATION

Item 1.           Financial Statements.

In the opinion of management,  the accompanying unaudited consolidated financial
statements included in this Form 10-QSB reflect all adjustments (consisting only
of normal recurring  accruals)  necessary for a fair presentation of the results
of  operations  for the periods  presented.  The results of  operations  for the
periods  presented are not necessarily  indicative of the results to be expected
for the full year.

<TABLE>
<S>                                                                                           <C>
Accountants' Review Report                                                                       3

Consolidated Balance Sheets as of June 30, 2006 and December 31, 2005                            4

Consolidated Statements of Operations for the three and six months ended
June 30, 2006 and 2005, and from inception (October 2, 1989) through June 30, 2006               5

Consolidated Statements of Changes in Stockholders' Equity from inception (October 2, 1989)
through June 30, 2006                                                                            6

Consolidated Statements of Cash Flows for the three and six months ended
June 30, 2006 and 2005, and from inception (October 2, 1989) through June 30, 2006               7

Notes to the Consolidated Financial Statements                                                 8-21
</TABLE>


                                       2
<PAGE>

                         BAUMANN, RAYMONDO & COMPANY PA
                         405 North Reo Street, Suite 200
                              Tampa, Florida 33609
                                 (813) 288-8826

             Report of Independent Registered Public Accounting Firm

Board of Directors
Medical Media Television, Inc.
Tampa, Florida

We have reviewed the  accompanying  consolidated  balance sheet of Medical Media
Television, Inc. as of June 30, 2006, and the related consolidated statements of
operations, stockholders' equity and cash flows for the three month periods then
ended.  These  consolidated  financial  statements are the responsibility of the
Company's management.

We conducted our reviews in accordance  with the standards of the Public Company
Accounting  Oversight  Board  (United  States).  A review of  interim  financial
information consists principally of applying analytical  procedures to financial
data and making  inquiries of persons  responsible  for financial and accounting
matters. It is substantially less in scope than an audit conducted in accordance
with the  standards  of the  Public  Company  Accounting  Oversight  Board,  the
objective  of which is the  expression  of an opinion  regarding  the  financial
statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should
be made to such consolidated  financial  statements for them to be in conformity
with U.S. generally accepted accounting principles.

As discussed in Note A, the Company has been in the development  stage since its
inception on October 2, 1989.  Realization  of a major  portion of its assets is
dependent on the Company's  ability to meet its future  financing  requirements,
and the success of its future operations.  These factors raise substantial doubt
about the  Company's  ability to  continue  as a going  concern.  The  financial
statements do not include any adjustments  that might result from the outcome of
this uncertainty.

/s/ Baumann, Raymondo & Company PA
BAUMANN, RAYMONDO & COMPANY PA
August 21, 2006


                                       3
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                           CONSOLIDATED BALANCE SHEET

<TABLE>
<CAPTION>

                                                                                  June 30,            December 31,
                                                                                    2006                 2005
                                                 ASSETS                           Unaudited             Audited
                                                                                 -----------          -----------
<S>                                                                             <C>                   <C>
Current assets:
      Cash                                                                       $    51,748          $    75,248
      Accounts receivable                                                             15,036                   --
      Prepaid expenses and other current assets                                       83,930               36,010
                                                                                 -----------          -----------
           Total current assets                                                      150,714              111,258
                                                                                 -----------          -----------
Fixed assets:
      Computer equipment                                                              20,728               19,585
      Leasehold improvements                                                           6,196                6,196
                                                                                 -----------          -----------
                                                                                      26,924               25,781
      Less accumulated depreciation                                                  (14,838)             (11,180)
                                                                                 -----------          -----------
                                                                                      12,086               14,601
                                                                                 -----------          -----------
Other assets:
      Goodwill                                                                     1,271,037            1,271,037
      Intangible assets                                                              260,417              300,000
      Security deposits                                                                7,596                7,596
                                                                                 -----------          -----------
           Total other assets                                                      1,539,050            1,578,633
                                                                                 -----------          -----------
           Total assets                                                          $ 1,701,850          $ 1,704,492
                                                                                 ===========          ===========

                                  LIABILITIES AND STOCKHOLDERS' DEFICIT

Current liabilities:
      Accounts payable                                                           $   563,810          $   530,175
      Accrued expenses and other current liabilities                                 671,489              512,899
      Deferred revenue                                                                32,448               22,485
      Notes payable to stockholders                                                2,906,467            1,496,437
                                                                                 -----------          -----------
           Total current liabilities                                               4,174,214            2,561,996
                                                                                 -----------          -----------
Long-term liabilities
      Note payable to stockholder                                                         --              250,000
      Deferred revenue                                                                 8,698               17,985
                                                                                 -----------          -----------
           Total long-term liabilities                                                 8,698              267,985
                                                                                 -----------          -----------
           Total liabilities                                                       4,182,912            2,829,981
                                                                                 -----------          -----------
      Stockholders' deficit:
         Preferred stock - no par value; 25,000,000 shares authorized;
           1,682,044 Series A Zero Coupon, shares issued and outstanding,
           2,612,329 Series B Zero Coupon, shares issued and outstanding,
           and 8,627 Series C Zero Coupon, shares issued and outstanding           4,303,000            4,303,000
         Common stock - par value $.0005; 100,000,000 shares authorized;
           21,117,136 and 20,725,104 shares issued and outstanding at
           June 30, 2006 and December 31, 2005 respectively                           10,558               10,363
         Additional paid-in capital                                                1,220,830            1,098,438
         Accumulated deficit during development stage                             (8,015,450)          (6,537,290)
                                                                                 -----------          -----------
            Total stockholders' deficit                                           (2,481,062)          (1,125,489)
                                                                                 -----------          -----------
            Total liabilities and stockholders' deficit                          $ 1,701,850          $ 1,704,492
                                                                                 ===========          ===========
</TABLE>


               The accompanying footnotes are an integral part of
                    these consolidated financial statements.

                                        4
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                 UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS
            FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2006 AND 2005
                FROM INCEPTION (OCTOBER 2, 1989) to JUNE 30, 2006


<TABLE>
<CAPTION>

                                                          June 30, 2006                   June 30, 2005
                                                  -----------------------------    ----------------------------        From
                                                  For the Three     For the Six    For the Three    For the Six    Inception to
                                                   Months Then      Months Then     Months Then     Months Then      June 30,
                                                      Ended            Ended           Ended           Ended           2006
                                                   ------------    ------------    ------------    ------------    ------------
<S>                                                <C>             <C>             <C>             <C>             <C>
Revenues, net                                      $    129,053    $    184,173    $     30,062    $     49,311    $    384,705

Cost of revenues                                         33,735          49,659          11,552          20,880          93,390
                                                   ------------    ------------    ------------    ------------    ------------
Gross profit                                             95,318         134,514          18,510          28,431         291,315
                                                   ------------    ------------    ------------    ------------    ------------
Operating expenses:
  DVD production costs                                   74,004         136,034          40,604          77,123         660,100
  General and administration                            230,001         610,376         241,897         414,467       3,879,036
  Sales and marketing                                   256,165         618,734          70,617         191,027       2,450,420
  Depreciation and amortization                          21,587          43,241           1,559           2,786         198,979
                                                   ------------    ------------    ------------    ------------    ------------
    Total operating expense                             581,757       1,408,385         354,677         685,403       7,188,535
                                                   ------------    ------------    ------------    ------------    ------------

Operating loss                                         (486,439)     (1,273,871)       (336,167)       (656,972)     (6,897,220)
                                                   ------------    ------------    ------------    ------------    ------------
Other income and (expense)
  Interest expense                                     (118,615)       (204,952)       (157,937)       (305,073)     (1,127,022)
  Interest income                                            70             174              --             951           2,039
  Other income                                               --             489              75             149           2,928
  Gain on sale of subsidiary                                 --              --              --              --           2,421
                                                   ------------    ------------    ------------    ------------    ------------
    Total other income (expense)                       (118,545)       (204,289)       (157,862)       (303,973)     (1,119,634)
                                                   ------------    ------------    ------------    ------------    ------------
Loss before extraordinary items                        (604,984)     (1,478,160)       (494,029)       (960,945)     (8,016,854)

  Gain on extinguishment of debt                             --              --              --              --           1,404
                                                   ------------    ------------    ------------    ------------    ------------
Loss before taxes                                      (604,984)     (1,478,160)       (494,029)       (960,945)     (8,015,450)

  Provision for income taxes                                 --              --              --              --              --
                                                   ------------    ------------    ------------    ------------    ------------
Net loss                                           $   (604,984)   $ (1,478,160)   $   (494,029)   $   (960,945)   $ (8,015,450)
                                                   ============    ============    ============    ============    ============
Net loss per share, basic and diluted              $      (0.03)   $      (0.07)   $      (0.38)   $      (0.73)   $      (6.12)
                                                   ============    ============    ============    ============    ============
Weighted average shares, basic and diluted           21,117,136      21,046,017       1,309,362       1,309,266       1,308,971
                                                   ============    ============    ============    ============    ============
</TABLE>


               The accompanying footnotes are an integral part of
                    these consolidated financial statements.

                                        5
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                 CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
        FOR PERIOD FROM INCEPTION (OCTOBER 2, 1989) THROUGH JUNE 30, 2006

<TABLE>
<CAPTION>

                                                                                                        Additional
                                                  Preferred Stock                Common Stock             Paid-in
                                               Shares         Amount         Shares        Amount         Capital
                                            -----------    -----------    -----------    -----------    -----------
<S>                                         <C>            <C>            <C>            <C>            <C>
Issuance of $0.01 par value common
 shares to an individual for a note                  --    $        --          1,000    $       100    $     1,900
Payment of subscription receivable                   --             --             --             --             --
Stock split 2,000:1 and change par                   --             --             --             --             --
 value from $0.01 to $0.0005                         --             --      1,999,000            900           (900)
                                            -----------    -----------    -----------    -----------    -----------

Balance, December 31, 1996                           --             --      2,000,000          1,000          1,000

Repurchase of shares                                 --             --             --             --             --
Issuance of common stock                             --             --      2,476,000          1,238          3,762
                                            -----------    -----------    -----------    -----------    -----------
Balance, December 31, 1997                           --             --      4,476,000          2,238          4,762
Net loss                                             --             --             --             --             --
                                            -----------    -----------    -----------    -----------    -----------

Balance, December 31, 1998                           --             --      4,476,000          2,238          4,762
                                            -----------    -----------    -----------    -----------    -----------
Balance, December 31, 1999                           --             --      4,476,000          2,238          4,762
Shares issued in connection
 with merger with Y2K Recording, Inc.                --             --      1,025,000            513             --
Net income                                           --             --             --             --             --
                                            -----------    -----------    -----------    -----------    -----------
Balance, December 31, 2000                           --             --      5,501,000          2,751          4,762

Shares issued in connection
 with merger with Savage Mojo, Inc.                  --             --      8,000,000          4,000             --
Shares issued for services                           --             --         10,000              5            995
Contributed capital                                  --             --             --             --          5,672
Net loss                                             --             --             --             --             --
                                            -----------    -----------    -----------    -----------    -----------
Balance, December 31, 2001                           --             --     13,511,000          6,756         11,429

Series A shares sold in private placement        47,750         95,500             --             --             --
Retire treasury stock                                --             --     (1,725,000)          (863)        (4,137)
Shares issued as premium for notes                   --             --      2,939,553          1,470             --
Shares issued for Cohen employment
 agreement                                           --             --        748,447            374         74,471
Cancellation of outstanding stock
 returned by M. Klimes                               --             --     (4,000,000)        (2,000)            --
Shares issued for services                           --             --        312,000            156         31,044
Payment of subscription receivable                   --             --             --             --             --
Write off of subscription receivable
Net loss                                             --             --             --             --             --

                                            -----------    -----------    -----------    -----------    -----------
Balance, December 31, 2002                       47,750         95,500     11,786,000          5,893        112,807

Shares issued for services                           --             --         50,000             25          4,975
Series A shares sold in private placement        53,500        107,000             --             --             --
Series B shares sold in private placement         1,000          2,000             --             --             --
Net loss                                             --             --             --             --             --
                                            -----------    -----------    -----------    -----------    -----------
Balance, December 31, 2003                      102,250        204,500     11,836,000          5,918        117,782

Conversion of Series A to common               (101,250)      (202,500)       525,959            263        202,237
Cancellation and refund of Series B              (1,000)        (2,000)
Shares issued for services                           --             --        372,583            186        101,828
Shares issued for debt                               --             --        357,143            179        249,821
Net loss                                             --             --             --             --             --
                                            -----------    -----------    -----------    -----------    -----------
Balance, December 31, 2004                           --             --     13,091,685          6,546        671,668

Effects of 30: 1 reverse stock split                 --             --    (12,654,986)        (6,327)         6,327
Issuance of dividend shares                          --             --        872,779            436           (436)
Conversion of debt to preferred               4,303,000      4,303,000
Acquisition of African American
  Medical Network, Inc.                                                    19,415,626          9,708        420,879
Net loss                                             --             --             --             --             --
                                            -----------    -----------    -----------    -----------    -----------
Balance, December 31, 2005                    4,303,000      4,303,000     20,725,104         10,363      1,098,438

Shares issued for services                                                    246,195            122         98,355
Warrants exercised                                                            145,837             73         24,037
Net loss                                             --             --             --             --             --
                                            -----------    -----------    -----------    -----------    -----------
Balance, June 30, 2006                        4,303,000    $ 4,303,000     21,117,136    $    10,558    $ 1,220,830
                                            ===========    ===========    ===========    ===========    ===========

<CAPTION>
                                                          Accumulated
                                                         Deficit during        Treasury Stock
                                            Subscription   Development    --------------------------
                                             Receivable       Stage         Shares         Amount          Total
                                            -----------    -----------    -----------    -----------    -----------
<S>                                         <C>            <C>           <C>             <C>            <C>
Issuance of $0.01 par value common
 shares to an individual for a note         $    (2,000)   $        --    $        --    $        --    $        --
Payment of subscription receivable                1,885             --             --             --          1,885
Stock split 2,000:1 and change par                   --             --             --             --             --
 value from $0.01 to $0.0005                         --             --             --             --             --
                                            -----------    -----------    -----------    -----------    -----------

Balance, December 31, 1996                         (115)            --             --             --          1,885

Repurchase of shares                                 --             --     (1,725,000)        (5,000)        (5,000)
Issuance of common stock                         (5,000)            --              .             --             --
                                            -----------    -----------    -----------    -----------    -----------
Balance, December 31, 1997                       (5,115)            --     (1,725,000)        (5,000)        (3,115)
Net loss                                             --         (2,867)            --             --         (2,867)
                                            -----------    -----------    -----------    -----------    -----------

Balance, December 31, 1998                       (5,115)        (2,867)    (1,725,000)        (5,000)        (5,982)
                                            -----------    -----------    -----------    -----------    -----------
Balance, December 31, 1999                       (5,115)        (2,867)    (1,725,000)        (5,000)        (5,982)
Shares issued in connection
 with merger with Y2K Recording, Inc.                --             --             --             --            513
Net income                                           --            434             --             --            434
                                            -----------    -----------    -----------    -----------    -----------
Balance, December 31, 2000                       (5,115)        (2,433)    (1,725,000)        (5,000)        (5,035)

Shares issued in connection
 with merger with Savage Mojo, Inc.                  --             --             --             --          4,000
Shares issued for services                           --             --             --             --          1,000
Contributed capital                                  --             --             --             --          5,672
Net loss                                             --        (57,151)            --             --        (57,151)
                                            -----------    -----------    -----------    -----------    -----------
Balance, December 31, 2001                       (5,115)       (59,584)    (1,725,000)        (5,000)       (51,514)

Series A shares sold in private placement            --             --             --             --         95,500
Retire treasury stock                                --             --      1,725,000          5,000             --
Shares issued as premium for notes                   --             --             --             --          1,470
Shares issued for Cohen employment
 agreement                                           --             --             --             --         74,845
Cancellation of outstanding stock
 returned by M. Klimes                               --             --             --             --         (2,000)
Shares issued for services                           --             --             --             --         31,200
Payment of subscription receivable                5,000             --             --             --          5,000
Write off of subscription receivable                115                                                         115
Net loss                                             --       (498,888)            --             --       (498,888)
                                            -----------    -----------    -----------    -----------    -----------

Balance, December 31, 2002                           --       (558,472)            --             --       (344,272)

Shares issued for services                           --             --             --             --          5,000
Series A shares sold in private placement            --             --             --             --        107,000
Series B shares sold in private placement            --             --             --             --          2,000
Net loss                                             --     (1,825,313)            --             --     (1,825,313)
                                            -----------    -----------    -----------    -----------    -----------
Balance, December 31, 2003                           --     (2,383,785)            --             --     (2,055,585)

Conversion of Series A to common                     --             --             --             --             --
Cancellation and refund of Series B                                                                          (2,000)
Shares issued for services                           --             --             --             --        102,014
Shares issued for debt                               --             --             --             --        250,000
Net loss                                             --     (2,188,203)            --             --     (2,188,203)
                                            -----------    -----------    -----------    -----------    -----------
Balance, December 31, 2004                           --     (4,571,988)            --             --     (3,893,774)

Effects of 30: 1 reverse stock split                 --             --             --             --             --
Issuance of dividend shares                          --             --             --             --             --
Conversion of debt to preferred                                                                           4,303,000
Acquisition of African American
  Medical Network, Inc.                                                                                     430,587
Net loss                                             --     (1,965,302)            --             --     (1,965,302)
                                            -----------    -----------    -----------    -----------    -----------
Balance, December 31, 2005                           --     (6,537,290)            --             --     (1,125,489)

Shares issued for services                                                                                   98,477
Warrants exercised                                                                                           24,110
Net loss                                             --     (1,478,160)            --             --     (1,478,160)
                                            -----------    -----------    -----------    -----------    -----------
Balance, June 30, 2006                       $       --    $(8,015,450)   $        --    $        --    $(2,481,062)
                                            ===========    ===========    ===========    ===========    ===========
</TABLE>


               The accompanying footnotes are an integral part of
                    these consolidated financial statements.

                                        6
<PAGE>
                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                 UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS
                 FOR THE SIX MONTHS ENDED JUNE 30, 2006 AND 2005
                FROM INCEPTION (OCTOBER 2, 1989) TO JUNE 30, 2006

<TABLE>
<CAPTION>

                                                                                                                 From
                                                                              Six Months Ended               Inception to
                                                                        ------------------------------         June 30,
                                                                        June 30, 2006    June 30, 2005           2006
                                                                        -------------    -------------       ------------
<S>                                                                     <C>                <C>               <C>
CASH FLOWS FROM OPERATING ACTIVITES
  Net loss                                                               $(1,478,160)      $  (960,945)      $(8,015,450)
     Adjustments to reconcile net loss to net cash flows from
        operating activities:
          Depreciation and amortization expense                               43,241             2,786            62,053
          Cash from acquisition of African American Medical
             Network, Inc.                                                        --                --             2,104
          Gain on sale of subsidiary                                              --                --            (2,421)
          Gain on extinguishment of debt                                          --                --            (1,404)
          Common stock issued for services                                    98,478                --           306,537
          Bad debt expense                                                        --           (10,000)               --
          Changes in assets and liabilities:
             Accounts receivable                                             (15,036)           19,470           (15,036)
             Other current receivables                                          (100)         (174,659)
             Prepaid expenses                                                (47,819)           22,922           (83,815)
             Other receivables                                                    --                              65,521
             Security deposits                                                    --                --            (7,596)
             Accounts payable                                                 33,635           202,022           155,185
             Accrued expenses and other current liabilities                  184,265           401,323         1,284,344
                                                                         -----------       -----------       -----------
Net cash flows (used) in operating activities                             (1,181,496)         (497,081)       (6,249,978)
                                                                         -----------       -----------       -----------
CASH FLOWS FROM INVESTING ACTIVITIES
  Purchase of equipment                                                       (1,143)           (5,226)          (25,170)
                                                                         -----------       -----------       -----------
Net cash flows (used) in investing activities                                 (1,143)           (5,226)          (25,170)
                                                                         -----------       -----------       -----------
CASH FLOWS FROM FINANCING ACTIVITIES
  Common stock issued for cash                                                    --                --            14,185
  Common stock issued for exercise of warrants                                24,110                --            24,110
  Preferred stock issued for cash                                                 --                --           202,500
  Proceeds from notes payable-net                                          1,135,029           500,000         6,086,201
                                                                         -----------       -----------       -----------
Net cash flows provided by financing activities                            1,159,139           500,000         6,326,996
                                                                         -----------       -----------       -----------
Increase (decrease) in cash                                                  (23,500)           (2,307)           51,848
Cash, beginning of period                                                     75,248            18,793                --
                                                                         -----------       -----------       -----------
Cash, end of period                                                      $    51,748       $    16,486       $    51,848
                                                                         ===========       ===========       ===========

               SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:

Cash paid for interest                                                   $   135,008       $       719       $   144,287
                                                                         ===========       ===========       ===========
Acquisition of African American Medical Network, Inc.                    $        --       $        --       $ 1,571,037
                                                                         ===========       ===========       ===========
Common Stock issued for debt                                             $        --       $        --       $   250,000
                                                                         ===========       ===========       ===========
Preferred Stock issued for debt                                          $        --       $        --       $ 4,303,000
                                                                         ===========       ===========       ===========
</TABLE>


               The accompanying footnotes are an integral part of
                    these consolidated financial statements.

                                        7
<PAGE>


                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 2006

NOTE A - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

Medical Media Television, Inc. ("Medical Media" or the "Company";  references to
"we," "our" or "us" also mean the Company) is a Florida corporation organized on
October 2, 1989.  We are a  development  stage  company  focused on  developing,
establishing and marketing educational programming for distribution on a monthly
basis to  participating  subscribers  to our  veterinary  network,  our  medical
network directed to the African American population,  and our pediatric network.
Our educational  programming is obtained  through an annual  subscription and is
funded,  in part,  by commercial  advertisers  who benefit from an effective and
convenient advertising medium to target their goods and services to the consumer
patients.   Our  goal  is  to  be   recognized   as  a   leading   provider   of
advertiser-supported  medical  education  programming  for  patients and clients
within  the  place-based   media   environment  of  medical   specialty  offices
nationwide.

We  provide   advertiser-supported   patient/parent/client   medical   education
programming  within the  place-based  media  environment  of  medical  specialty
offices  nationwide.  We have three  wholly-owned  operating  subsidiaries:  (1)
PetCARE  Television  Network,  Inc. ("PetCARE TV"), (2) African American Medical
Network,  Inc.  ("African  American Medical  Network");  and (3) KidCARE Medical
Television Network, Inc. ("KidCARE TV"). As discussed in more detail below, each
of our subsidiaries targets a different consumer base.

Medical  Media  produces  monthly  DVD  magazines  that are  distributed  to the
participating subscribers of PetCARE TV and African American Medical Network. We
plan to provide  monthly  updated  programming  for  KidCARE  TV either  through
monthly DVD  magazines  or through  direct video  streaming at each  subscribing
location. The programming is funded, in part, by commercial advertisers that are
reviewed and  approved by the  advisory  boards  serving  each  subsidiary.  Our
programming is obtained through an annual  subscription with updated programming
provided directly to the subscribers.

PetCARE TV

PetCARE TV's goal is to provide  animal health and welfare  education to a large
number of  consumers of pet  products  and  services  while  serving as a unique
advertising  medium for  companies  that market  those goods and  services.  Our
educational  programming is currently aired in veterinary  practices  across the
U.S.,  Canada,  Puerto Rico, and Australia  where it is viewed by an estimated 4
million  pet owners each  month.  Each month  PetCARE TV provides an updated DVD
magazine focused on optimal  healthcare for animal  companions.  PetCARE TV also
sells an instructional  DVD to veterinarians  for them to give to their clients,
entitled "Welcome Home Your New Friend".

African American Medical Network

African American Medical Network's goal is to provide educational programming to
doctor's offices nationwide serving African American patients, and to provide an
advertising medium for commercial advertisers to target their goods and services
to these consumer  patients.  Our educational  programming is currently aired in
hundreds of physician offices across the U.S. and is targeted to the patients of
the more than  15,000  doctors  who serve the  majority  of the 35 million  U.S.
African Americans.


                                       8
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 2006

NOTE A - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

KidCARE TV

KidCARE TV will target parent consumers in pediatric  waiting rooms  nationwide.
KidCARE  TV is not yet  operational,  but  plans to  establish  a  collaborative
interaction with the viewing audience through its short  informational  segments
developed to create  awareness about  preventative  health  measurers along with
specific  childhood  illnesses  and  issues.  These  segments  are  designed  to
stimulate  the  viewer  to  seek  further  guidance  from  their   pediatrician.
Interspersed   throughout   the   segments,   promotional   pieces  will  appear
demonstrating  related  health  care  items.  KidCARE  TV's  primary  target for
subscribership will be members of the American Academy of Pediatrics.

Basis of Accounting

Medical Media  maintains its financial  records and financial  statements on the
accrual basis of  accounting.  The accrual  basis of  accounting  provides for a
better matching of revenues and expenses.

Interim Information

The accompanying  unaudited  consolidated  financial statements of Medical Media
have been prepared in accordance with accounting  principles  generally accepted
in the United States of America for interim  financial  information and with the
instructions to Form 10-QSB and Rule 10-01 of Regulation  S-X. All  adjustments,
which,  in the opinion of management,  are necessary for a fair  presentation of
the financial condition and results of operations, have been included. Operating
results  for the three month and six month  periods  ended June 30, 2006 are not
necessarily  indicative  of the results that may be expected for the year ending
December 31, 2006.

Cash and Cash Equivalents

For  purposes  of the  Consolidated  Statements  of Cash  Flows,  Medical  Media
considers amounts held by financial institutions and short-term investments with
an original maturity of 90 days or less to be cash and cash equivalents.

Fiscal Year

Medical Media elected December 31 as its fiscal year.

Revenue Recognition

The Company generates revenue from three primary sources,  namely advertisers on
its  DVD  magazines  (the  "Advertisers"),   subscribers  to  its  network  (the
"Subscribers"),  and the sale of our  instructional  DVD,  Welcome Home Your New
Friend.  With regard to  Advertisers,  the Company  recognizes  revenue over the
periods in which the advertisers'  commercials appear on its DVD magazine.  With
regard to Subscribers,  revenue is recognized proportionately over the length of
the  subscription  agreement  entered  into by the  Subscribers.  With regard to
Welcome Home Your New Friend,  revenue is  recognized in the period the DVDs are
shipped.


                                       9
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 2006

NOTE A - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Income Taxes

Medical Media  records its federal and state tax  liability in  accordance  with
Financial  Accounting  Standards  Board Statement No. 109 "Accounting for Income
Taxes".  The  deferred  taxes  payable are recorded  for  temporary  differences
between the  recognition of income and expenses for tax and financial  reporting
purposes, using current tax rates. Deferred assets and liabilities represent the
future tax  consequences of those  differences,  which will either be taxable or
deductible when the assets and liabilities are recovered or settled.

Since its  inception,  Medical Media has an  accumulated  loss of $8,015,450 for
income tax purposes,  which can be used to offset future  taxable income through
2023. The potential tax benefit of this loss is as follows:

                  Future tax benefit                 $2,404,635
                  Valuation allowance                (2,404,635)
                                                     ----------
                  Future tax benefit                 $       --
                                                     ==========

As of June 30,  2006,  no  deferred  taxes  were  recorded  in the  accompanying
financial statements.

Advertising Costs

Medical Media  expenses the production  costs of advertising  the first time the
advertising takes place.

Fixed Assets

Medical  Media's fixed assets consist of computer  equipment  being  depreciated
over 3 years and leasehold  improvements  being  depreciated  over the remaining
life of the current lease.

Going Concern

We currently are a development stage company under the provisions of SFAS No. 7,
and have  negative  cash  flows from  operations  and no  established  source of
revenue.  We do not anticipate  significant  revenues from advertising  sales or
subscription sales until the fourth quarter of 2006. The foregoing matters raise
substantial  doubt  about the  ability  of our  Company to  continue  as a going
concern;  however,  as a result of a financing recently completed in August 2006
in which the Company  received  total cash proceeds of $790,000 and  anticipated
revenues, management now believes that there will be sufficient cash to continue
the business for at least the next twelve months.

Use of Estimates

Our  financial  statements  have been  prepared in  accordance  with  accounting
principles  generally  accepted in the United States.  The  preparation of these
financial  statements  requires us to make  significant  estimates and judgments
that affect the reported amounts of assets, liabilities,  revenues, expenses and
related  disclosure  of  contingent  assets and  liabilities.  We  evaluate  our
estimates, including those related to contingencies, on an


                                       10
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 2006

NOTE A - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

ongoing  basis.  We base our estimates on historical  experience  and on various
other  assumptions that are believed to be reasonable  under the  circumstances,
the  results  of which form the basis for making  judgments  about the  carrying
values of assets  and  liabilities  that are not  readily  apparent  from  other
sources.  Actual  results  may  differ  from  these  estimates  under  different
assumptions or conditions.

NOTE B - COMMON AND PREFERRED STOCK

Start of trading on the OTC Bulletin Board

On  February  2,  2004,  Medical  Media's  Common  Stock  began  trading  on the
OTC-Bulletin  Board under the symbol PTNW. In April 2005,  our symbol changed to
"MMTV".  There is a limited  public  trading  market for our Common  Stock and a
regular, more active trading market may not develop, or if developed, may not be
sustained.

Common Stock

On April 5, 2005,  the Company  combined  its issued and  outstanding  shares of
Common Stock on a 1:30 basis effective as of May 4, 2005.

On January 10, 2006, the Company  issued 10,000 shares of its restricted  Common
Stock to each  member  of the  PetCARE  TV  Veterinary  Advisory  Board in their
advisory capacities, for an aggregate of 130,000 shares.

On January 10, 2006, the Company  issued 10,000 shares of its restricted  Common
Stock to each member of the African  American  Medical Network Medical  Advisory
Board in their advisory capacities, for an aggregate of 60,000 shares.

On January 18, 2006, the Company  issued 56,195 shares of its restricted  Common
Stock to  Jeffery  Werber,  DVM,  a  director  and  Chairman  of the  PetCARE TV
Veterinary Advisory Board, in satisfaction of invoices totaling $22,478.

On March 6, 2006,  the Company  issued  41,670 shares of its  restricted  Common
Stock to Vicis  Capital  Master  Fund upon the  exercise  of its Series C Common
Stock Purchase  Warrants through the payment of $6,917.22 to the Company.  These
shares were  registered  under a  registration  statement  on Form SB-2 that was
declared effective by the Securities & Exchange Commission on March 1, 2006.

On March 6, 2006, the Company  issued  104,167  shares of its restricted  Common
Stock to Vicis  Capital  Master  Fund upon the  exercise  of its Series F Common
Stock Purchase Warrants through the payment of $17,192.71 to the Company.  These
shares were  registered  pursuant to a registration  statement on Form SB-2 that
was declared effective by the Securities & Exchange Commission on March 1, 2006.


                                       11
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 2006

NOTE B - COMMON AND PREFERRED STOCK (Continued)

Preferred stock

Series A Zero Coupon Preferred Stock

The Company's Series A Zero Coupon  Preferred Stock is non-voting  capital stock
with a stated  value of $1.00 per share and is  convertible  into the  Company's
Common  Stock at the option of the holder any time after the date of issuance at
the  initial  rate  of  $2.40  per  share.  In the  event  of any  voluntary  or
involuntary liquidation,  dissolution, or winding up of the Company, the holders
of shares of Series A Zero Coupon Preferred Stock are entitled to be paid out of
the assets  available  for  distribution  an amount  equal to One Million  Three
Hundred  Seventy  Five  Thousand  and  No/100  Dollars  ($1,375,000).  There are
currently  1,682,044  shares of Series A Zero Coupon  Preferred Stock issued and
outstanding.  The common shares  underlying  the Series A Zero Coupon  Preferred
Stock were included in a registration  statement on Form SB-2 filed with the SEC
which was declared effective on March 1, 2006.

Series B Zero Coupon Preferred Stock

The Company's Series B Zero Coupon  Preferred Stock is non-voting  capital stock
with a stated  value of $1.00 per share and is  convertible  into the  Company's
Common  Stock at the option of the holder any time after the date of issuance at
the initial rate of $3.00 per share.  Of the  2,612,329  shares of Series B Zero
Coupon  Preferred  Stock issued and  outstanding,  Vicis Capital owns  2,551,918
shares at an adjusted conversion price of $0.166 per share and Mark Maltzer owns
60,411  shares  at a  conversion  rate of $2.40 per  share.  In the event of any
voluntary or involuntary liquidation, dissolution, or winding up of the Company,
the holders of shares of Series B Zero Coupon Preferred Stock are entitled to be
paid out of the assets available for distribution  after taking into account the
Series A Zero Coupon  Preferred  Stock  liquidation  preference,  but before any
payment  shall be made to the  holders  of Common  Stock or any  other  class or
series  of stock  ranking  on  liquidation  junior to the  Series B Zero  Coupon
Preferred  Stock,  an amount  equal to Two Million  Three  Hundred  Thousand and
No/100  Dollars  ($2,300,000).  The common shares  underlying  the Series B Zero
Coupon  Preferred  Stock were included in a registration  statement on Form SB-2
filed with the SEC that was declared effective on March 1, 2006.

Series C Zero Coupon Preferred Stock

The Company's Series C Zero Coupon  Preferred Stock is non-voting  capital stock
and has a stated value of $1.00 per share and is convertible  into the Company's
Common  Stock at the option of the  holder  any time after the date of  issuance
into that number of shares of our Common Stock determined by dividing the number
of shares of Preferred Stock by the conversion  price  (initially equal to a ten
percent  (10%)  discount to the  then-current  market price based on the average
closing price for the twenty (20) days immediately preceding the conversion.  In
the event of any voluntary or involuntary liquidation,  dissolution,  or winding
up of the Company, the holders of shares of Series C Zero Coupon Preferred Stock
are  entitled  to be paid out of the assets  available  for  distribution  after
taking  into  account  the  liquidation  preference  of the Series A Zero Coupon
Preferred Stock and Series B Zero Coupon Preferred Stock, but before any payment
shall be made to the  holders  of Common  Stock or any other  class or series of
stock ranking on liquidation junior to the Series C Zero Coupon Preferred Stock,
an amount equal to Four Hundred  Thousand and No/Dollars  ($400,000).  There are
currently  8,627  shares of Series C Zero  Coupon  Preferred  Stock  issued  and
outstanding.  The pool of common  shares  underlying  the  Series C Zero  Coupon
Preferred  Stock were  included in a  registration  statement on Form SB-2 filed
with the SEC that was declared on effective on March 1, 2006.


                                       12
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 2006

NOTE B - COMMON AND PREFERRED STOCK (Continued)

Treasury stock

Treasury stock is shown at cost.

Stock Options

We have an equity  incentive plan available to key employees and  consultants of
the Company.  Under the plan,  we may grant  options for up to 66,667  shares of
Common  Stock.  In October  2003,  the Company  granted 5,300 options under this
equity  incentive  plan.  On March 23, 2006,  the  Company's  Board of Directors
approved  the granting of the  remaining  61,317  options.  With the issuance of
these options in April 2006, the 2002 Equity Incentive Plan was closed.

Effective  July 25,  2006,  by written  action  completed  on August 7, 2006,  a
majority  of  the  Company's   shareholders  approved  the  2006  Medical  Media
Television,  Inc.  Equity  Incentive Plan with an effective date of May 1, 2006.
Under the plan, we may grant options for up to 2,500,000 shares of Common Stock.
The Company has authorized  the issuance of 654,636  shares under  non-qualified
options under this plan.

NOTE C - RELATED PARTY TRANSACTIONS

On May 16,  2002,  we issued a  non-interest  bearing  promissory  note to James
Calaway,  a former director,  in the original  principal amount of $100,000 (the
"Calaway Note"). At June 30, 2006, the principal balance due on the Calaway Note
was $60,999.

In June 2002, we issued the following non-interest bearing promissory notes (the
"Hugo/Turner Notes"), all of which remained outstanding at June 30, 2006:

      Daniel V. Hugo, a former officer and director, in the amount of $25,000;
      Robert and Janna Hugo, in the amount of $6,000; and Robert and
      Jamie Turner, in the amount of $5,000.

At June 30,  2006,  the  principal  balances due on the  Hugo/Turner  Notes were
$16,668, $4,000, and $3,332 respectively.

NOTE D - CONVERTIBLE PROMISSORY NOTES

On May 6, 2005,  the Company  issued to Vicis  Capital  Master Fund  ("Vicis") a
Series B Convertible  Debenture  (the  "Debenture")  in the principal  amount of
$250,000,  and  related  Series D, Series E and Series F Common  Stock  Purchase
Warrants.  The Debenture has a term of 24 months and accrues  interest an annual
rate of fifteen  percent  (15%).  The Company has the option to pay  interest in
cash or in shares of its registered common stock at a ten percent (10%) discount
to the  market  price,  as  calculated  pursuant  to the  express  terms  of the
Debenture.  At  maturity,  Vicis may  convert the  Debenture  into shares of the
Company's  Common Stock at a price of $2.40 per share.  On October 19, 2005, the
conversion  price was reduced to $0.166  pursuant to the extension  terms of the
Series AA Convertible Debenture described in further detail below.


                                       13
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 2006

NOTE D - CONVERTIBLE PROMISSORY NOTES (Continued)

On November 16, 2005, the Company issued Series AA Convertible Debenture, Series
AA Common Stock Purchase Warrants,  and Series BB Common Stock Purchase Warrants
to Vicis.  Pursuant to the terms of the Series AA Convertible  Debenture,  Vicis
loaned the  Company an  aggregate  of  $412,000 at an annual rate of interest of
sixteen  percent  (16%).  The Series AA  Convertible  Debenture was cancelled on
August 11, 2006 and the principal  amount due  thereunder,  plus all accrued and
unpaid interest  through August 11, 2006,  became part of a Secured  Convertible
Promissory Note dated August 11, 2006 in the amount of $1,302,000.  The terms of
the Secured Convertible Promissory Note are described in detail below.

On November  16,  2005,  the Company  issued a  Promissory  Note for $100,000 to
Laurence Wallace (the "Wallace  Promissory  Note").  The Wallace Promissory Note
accrues  interest at an annual rate of eight  percent (8%). On the maturity date
of the  Wallace  Promissory  Note,  Wallace  has the  option  to  execute a debt
conversion  agreement under which the principal amount of the Wallace Promissory
Note will be converted into 100,000 units of the Company's securities, each unit
consisting of (i) two shares of Medical  Media's  Common Stock (for an aggregate
of 200,000  shares),  and (ii) one Common Stock Purchase  Warrant to purchase an
additional  share of Medical  Media's  Common Stock (for an aggregate of 100,000
warrants) with an exercise price of $1.00 per share. The Wallace Promissory Note
was due on April 17,  2006.  The  Company is in the  process of  negotiating  an
extension of the Maturity  Date,  however,  the Company may be  unsuccessful  in
negotiating such an extension.

On November  16,  2005,  the Company  issued a  Promissory  Note for $200,000 to
Carmen Bernstein (the "Bernstein  Promissory  Note").  The Bernstein  Promissory
Note accrues  interest at an annual rate of ten percent  (10%).  On the maturity
date of the  Bernstein  Promissory  Note,  Bernstein has the option to execute a
debt  conversion  agreement  under which the  principal  amount of the Bernstein
Promissory   Note  will  be  converted  into  200,000  units  of  the  Company's
securities,  each unit consisting of (i) one share of the Medical Media's common
stock (for an aggregate of 200,000 shares),  and (ii) one warrant to purchase an
additional  share of Medical  Media's  common stock (for an aggregate of 200,000
warrants)  with an exercise price of $2.00 per share.  The Bernstein  Promissory
Note was due on December 14, 2005,  and, as of the date of this filing,  has not
been  repaid  although  it has  been  extended  indefinitely  by  mutual  verbal
agreement.

On  November  30,  2005,  the  Company  issued to William  H.  Quiros a 12-month
Convertible  Promissory  Note  ("November  Quiros  Note")  for  $1,000,000  with
interest  accruing  at the rate of twenty  percent  (20%) per annum,  compounded
semi-annually.  Interest was to be paid at the end of each  calendar  quarter in
either shares of Series C Zero Coupon  Preferred  Stock of the Company valued at
$1.00 per share,  or cash,  at the option of  Quiros.  The Series C Zero  Coupon
Preferred  Stock would convert into shares of the Company's  Common Stock on the
maturity date of the November Quiros Note at a ten percent (10%) discount to the
then-current market price based on the average closing price for the twenty (20)
days  immediately  preceding  the  conversion.  On December 31, 2005 the Company
issued 8,627 shares of its Series C Zero Coupon  Preferred  Stock as payment for
$8,627  interest  accrued  through  December  31,  2005.  The 8,627  shares  are
convertible into 9,586 shares of the Company's Common Stock. At maturity, Quiros
had the option to convert the  November  Quiros  Note into  Common  Stock of the
Company at a fixed  conversion  price of $.40 per share. The Company also issued
Quiros five-year Common Stock Purchase Warrants ("Quiros  Warrants") to purchase
an aggregate of 2,500,000  shares of common stock at a Fixed  Exercise  price of
$0.75 per share. On July 28, 2006, the Company and Quiros agreed to amend


                                       14
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 2006

NOTE D - CONVERTIBLE PROMISSORY NOTES (Continued)

the terms of the  November  Quiros Note as follows:  (i) the  Maturity  Date was
extended to November 30, 2008; (ii) the note would not be convertible  until the
Maturity Date;  (iii) the Company would have the option to repay the note at any
time  prior to the  Maturity  Date;  (iv) the  conversion  price on the note was
changed  to  an  amount  equal  to  a  twenty  percent  (20%)  discount  to  the
then-current market price based on the average closing price for the twenty (20)
days immediately preceding the conversion,  but in no event less than $0.166 per
share; (v) quarterly  interest  payments on the note would be applied toward the
balance  remaining unpaid under the March Quiros Note (as described below) until
such time as the entire  $450,000  under the March Quiros Note has been received
by the Company,  at which time all future  interest  will  accrue,  but will not
become due and payable until the maturity  date; and (vi) certain price ratchets
were deleted.  The November  Quiros Warrants were also amended to delete certain
price  ratchets.  The  November  Quiros Note and the  accompanying  Common Stock
Purchase  Warrants are not convertible or exercisable  such that Quiros' overall
Common Stock ownership position in the Company exceeds 4.99%; provided, however,
that upon Quiros  providing  the Company  with  sixty-one  (61) days notice (the
"Waiver Notice") that he would like to waive this restriction with regard to any
or all shares of Common Stock issuable upon exercise of the  conversion  feature
of the November Quiros Note, this restriction will be of no force or effect with
regard to all or a portion of the November  Quiros Note referenced in the Waiver
Notice, and provided further that this provision shall be of no further force or
effect during the sixty-one  (61) days  immediately  preceding the expiration of
the term of the November Quiros Note.

On January 27, 2006,  the Company and  CapitalSmart,  LLC, a California  limited
liability  corporation,  ("CSmart")  entered  into  a  Note  Purchase  Agreement
pursuant to which CSmart  agreed to loan the Company an aggregate of  $1,000,000
through  installments of $250,000 on February 15, 2006 and $750,000 on March 31,
2006. As of July 28, 2006, Csmart had loaned the Company  $624,580.50.  The Note
Purchase  Agreement  provided  that  the  Company  issue  Csmart  a  convertible
promissory  note in the  original  aggregate  face  amount  of  $1,000,000  (the
"CapitalSmart  Note") and five-year  Common Stock Purchase  Warrants to purchase
2,500,000  shares of the  Company's  Common Stock (the "CSmart  Warrants")  at a
Fixed Exercise  Price of $0.75 per share.  The Company has issued CSmart 625,000
Warrants.  Pursuant  to the terms of the Note  Purchase  Agreement,  the Company
issued the CSmart  Note on  February  15,  2006.  The CSmart  Note was to mature
twelve  months  from the date of  issuance  (the  "Maturity  Date") and  accrued
interest at a rate of 20%  (compounded  semi-annually).  Interest was payable at
the end of each  quarter  in either (i)  shares of the  Company's  Series C Zero
Coupon  Preferred Stock valued a $1.00 per share, or (ii) cash, at the option of
CSmart.  The first interest  payment due on March 31, 2006 of $6,438 was paid on
April 1, 2006. On the Maturity Date, CSmart had the option to convert the CSmart
Note into shares of the Company's  Common Stock at a fixed  conversion  price of
$0.40 per share.  On July 28, 2006,  CSmart and the Company agreed to cancel the
Csmart Note and the outstanding  625,000 CSmart  Warrants,  and to issue in lieu
thereof,  separate replacement  convertible promissory notes and warrants to the
principals of CSmart or to entities  controlled by the principals of CSmart.  In
accordance therewith,  four convertible  promissory notes in an aggregate amount
equal to $1 million were issued to: Softrev Partners, Inc. for $250,000, Gilbert
B. Ross for  $200,000,  William H.  Quiros  for  $450,000,  and Steven  Port for
$100,000.  The notes,  described in detail herein,  were issued on July 28, 2006
with an  effective  date as to when  each  principal  contributed  funds  to the
Company to be applied toward the CSmart note balance.

On February 15, 2006, the Company issued a Convertible Promissory Note to Steven
J. Port for  $100,000  (the  "February  Port Note") and  five-year  Common Stock
Purchase  Warrants to purchase 250,000 shares of the Company's Common Stock at a
Fixed Conversion Price of $0.75 per share (the "February Port


                                       15
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 2006

NOTE D - CONVERTIBLE PROMISSORY NOTES (Continued)

Warrants").  The February Port Note was issued as a partial  replacement for the
CSmart Note for $1,000,000  described  above. The February Port Note will mature
twelve  months  from the date of  issuance  (the  "Maturity  Date") and  accrues
interest  at the rate of 20%  compounded  semi-annually.  At the option of Port,
interest  will be paid at the end of each  quarter  in either  (i) shares of the
Company's Series C Zero Coupon Preferred Stock valued a $1.00 per share, or (ii)
cash.  The Port Note is not be  convertible  until the Maturity  Date.  With the
consent of both the Company and Port, the February Port Note may be extended for
an  additional 12 months with the terms of the interest  payments  remaining the
same.  On the Maturity  Date,  Port has the option to convert the February  Port
Note into shares of the  Company's  Common Stock at a price equal to forty cents
($0.40),  or  an  amount  equal  to a  twenty  percent  (20%)  discount  to  the
then-current market price based on the average closing price for the twenty (20)
days  immediately  preceding  the  conversion,   with  the  exception  that  the
Conversion Price shall not be lower than $0.166.

On February  16,  2006,  the Company  issued a  Convertible  Promissory  Note to
Gilbert B. Ross for  $200,000  (the  "Ross  Note") and  five-year  Common  Stock
Purchase  Warrants to purchase 500,000 shares of the Company's Common Stock at a
Fixed Conversion Price of $0.75 per share (the "Ross  Warrants").  The Ross Note
was issued as a partial replacement for the CSmart Note for $1,000,000 described
above.  The Ross Note will mature  three  years from the date of  issuance  (the
"Maturity  Date") and accrues  interest at the rate of twenty  percent (20%) per
annum.  Interest accrues but is not due and payable until the Maturity Date. The
Ross Note is not  convertible  until the Maturity Date. With the consent of both
the Company and Ross,  the Ross Note may be extended for an additional  12-month
term,  with the  terms of the  interest  payments  remaining  the  same.  On the
Maturity  Date,  Ross has the option to convert the Ross Note into shares of the
Company's  Common Stock at a price equal to a twenty  percent (20%)  discount to
the then-current  market price based on the average closing price for the twenty
(20)  days  immediately  preceding  the  conversion,  but in no event  shall the
Conversion Price be less than $0.166 per share.

On March 31, 2006, the Company issued a Convertible  Promissory  Note to William
H. Quiros for $450,000 (the "March  Quiros Note") and agreed to issue  five-year
Common Stock  Purchase  Warrants to purchase  1,125,000  shares of the Company's
Common Stock at a Fixed  Conversion  Price of $0.75 per share (the "March Quiros
Warrants").  The March Quiros Note was issued as a partial  replacement  for the
CSmart Note for $1,000,000  described  above.  The March Quiros Note will mature
three years from the date of issuance (the "Maturity Date") and accrues interest
at a rate of twenty percent (20%) per annum. Interest accrues but is not due and
payable until the Maturity Date. The March Quiros Note is not convertible  until
the Maturity  Date.  With the consent of both the Company and Quiros,  the March
Quiros Note may be extended for an additional  12-month term,  with the terms of
the interest  payments  remaining the same. On the Maturity Date, Quiros has the
option to convert  the March  Quiros Note into  shares of the  Company's  Common
Stock at a price equal to a twenty  percent (20%)  discount to the  then-current
market  price  based on the  average  closing  price  for the  twenty  (20) days
immediately preceding the conversion, but in no event shall the Conversion Price
be less than $0.166 per share.

On March 31, 2006, the Company issued a Convertible Promissory Note to Elaine G.
Edinburg for $10,000 (the "Edinburg  Note") and five-year  Common Stock Purchase
Warrants to purchase  25,000  shares of the  Company's  Common  Stock at a Fixed
Conversion Price of $0.75 per share (the "Edinburg Warrants"). The Edinburg Note
matures  twelve  months  from the date of  issuance  (the  "Maturity  Date") and
accrues interest at a rate of twenty percent (20%) compounded semi-annually.  At
the  option of  Edinburg,  interest  will be paid at the end of each  quarter in
either (i) shares of the Company's Series C


                                       16
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 2006

NOTE D - CONVERTIBLE PROMISSORY NOTES (Continued)

Zero  Coupon  Preferred  Stock  valued a $1.00 per share,  or (ii) cash.  On the
Maturity Date,  Edinburg had the option to convert the Edinburg Note into shares
of the Company's  Common Stock at a Fixed  Conversion  Price of $0.40 per share.
With the consent of both the  Company and  Edinburg,  the  Edinburg  Note may be
extended  for an  additional  twelve (12) months with the terms of the  interest
payments  remaining the same. On June 20, 2006,  Edinburg and the Company agreed
to amend the Edinburg Note and Edinburg Warrants as follows:  (i) the conversion
price was  changed to the  Investor's  option of an amount  equal to forty cents
($0.40)  or  an  amount  equal  to  a  twenty  percent  (20%)  discount  to  the
then-current market price based on the average closing price for the twenty (20)
days  immediately  preceding  the  conversion,   with  the  exception  that  the
Conversion  Price shall not be lower than $0.166;  and (ii) price  ratchets were
deleted.

On April 1, 2006, the Company issued a Convertible  Promissory Note to Steven J.
Port for $125,000  made in  installments  (the "April Port Note") and  five-year
Common  Stock  Purchase  Warrants to purchase  312,500  shares of the  Company's
Common  Stock at a Fixed  Conversion  Price of $0.75 per share (the  "April Port
Warrants"). The original maturity date of the April Port Note was April 30, 2006
and interest  accrues at the rate of twenty  percent  (20%) per annum.  Interest
accrues, but is not due and payable until the Maturity Date. The April Port Note
automatically extends to the end of each succeeding month until such time as the
Port  provides a 15-day  written  notice to the Company that the April Port Note
may no longer be automatically  extended.  The terms of interest will remain the
same throughout the automatic  extension periods. On the Maturity Date, Port has
the option to convert  the April Port Note into shares of the  Company's  Common
Stock at a price equal to an amount equal to forty cents  ($0.40),  or an amount
equal to a twenty percent (20%) discount to the then-current  market price based
on the average closing price for the twenty (20) days immediately  preceding the
conversion, with the exception that the Conversion Price shall not be lower than
$0.166.

On April 16, 2006, the Company issued a Convertible  Promissory  Note to Softrev
Partners,  Inc. for $250,000  (the "Softrev  Note") and  five-year  Common Stock
Purchase  Warrants to purchase 625,000 shares of the Company's Common Stock at a
Fixed Conversion Price of $0.75 per share (the "Softrev Warrants").  The Softrev
Note was  issued as a partial  replacement  for the CSmart  Note for  $1,000,000
described  above. The Softrev Note matures three years from the date of issuance
(the "Maturity Date") and accrues interest at a rate of twenty percent (20%) per
annum.  Interest accrues but is not due and payable until the Maturity Date. The
Softrev Note shall not be convertible  until the Maturity Date. With the consent
of both the  Company  and  Softrev,  the  Softrev  Note may be  extended  for an
additional  12-month term, with the terms of the interest payments remaining the
same. On the Maturity  Date,  Softrev has the option to convert the Softrev Note
into shares of the Company's  Common Stock at a price equal to a twenty  percent
(20%)  discount to the  then-current  market price based on the average  closing
price for the twenty (20) days immediately  preceding the conversion,  but in no
event shall the Conversion Price be less than $0.166 per share.

On June 1,  2006,  the  Company  issued a Secured  Promissory  Note to Vicis for
$50,000  ("Vicis  June 1 Secured  Note").  The Vicis June 1 Secured  Note was to
mature on December 31, 2006 and accrued  interest at a rate of eighteen  percent
(18%) per annum.  The Vicis  June 1 Secured  Note was  secured  by all  accounts
receivable due from Butler Animal Health Supply after June 1, 2006, or any other
money due the Company from any and all other  sources.  The Vicis June 1 Secured
Note could be prepaid in whole or in part at any time, with a prepayment penalty
of $5,492.25.  On August 11, 2006,  Vicis  surrendered  the Vicis June 1 Secured
Note  as  partial   consideration  for  the  Company's  issuance  of  a  Secured
Convertible Promissory Note in the principal amount of $1,302,000.


                                       17
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 2006

NOTE D - CONVERTIBLE PROMISSORY NOTES (Continued)

On June 30,  2006,  the Company  issued a Secured  Promissory  Note to Vicis for
$50,000  ("Vicis June 30 Secured  Note").  The Vicis June 30 Secured Note was to
mature on January 31, 2007 and  accrued  interest at a rate of eighteen  percent
(18%) per  annum.  The Vicis June 30 Secured  Note was  secured by all  accounts
receivable  due from Butler  Animal  Health  Supply after June 30, 2006,  or any
other money due the Company  from any and all other  sources.  The Vicis June 30
Secured Note could be prepaid in whole or in part at any time, with a prepayment
penalty of $5,492.25.  On August 11, 2006,  Vicis  surrendered the Vicis June 30
Secured Note as partial  consideration  for the Company's  issuance of a Secured
Convertible Promissory Note in the principal amount of $1,302,000.

On August 11, 2006, the Company issued a 10% Secured Convertible Promissory Note
in the  principal  amount of  $1,302,000  (the "Note") to Vicis  pursuant to the
terms of that certain Note Purchase Agreement (the "Purchase Agreement") of even
date therewith.  As consideration for the Note, Vicis (a) delivered  $790,000 in
cash (the "Cash Payment");  (b) surrendered two secured  promissory notes issued
by the Company to Vicis on June 1, 2006, and June 30, 2006,  respectively,  each
in the principal  amount of $50,000  (collectively,  the "June Notes");  and (c)
surrendered a Series AA Convertible  Debenture No. 05-0719 issued by the Company
to  Vicis  on  July  19,  2005,  in  the  principal   amount  of  $412,000  (the
"Debenture"). At any time while the Note remains outstanding,  Vicis may convert
the  outstanding  principal  balance and any accrued but unpaid  interest on the
Note into shares of the Company's common stock, par value $.0005 per share, at a
conversion  price of $.166 per share (the  "Conversion  Shares").  The principal
balance of the Note is due,  in one lump sum  payment,  on August 10,  2007 (the
"Maturity Date"),  unless earlier converted.  Interest on such principal (or any
balance  thereof  outstanding  from time to time)  accrues at an annual  rate of
interest of ten percent (10%). As so accrued,  interest shall be due and payable
to Vicis on the Maturity  Date. If the Company  commits any Event of Default (as
defined in the Purchase  Agreement),  then the unpaid  principal  amount of, and
accrued  interest  on, the Note may be  accelerated  by Vicis and become due and
payable,  whereupon  the  interest  rate shall be  increased to a rate of twenty
percent  (20%) per annum,  subject to the  limitations  of  applicable  law.  As
security for the  Company's  obligations  under the Purchase  Agreement  and the
Note,   the  Company   pledged  all  of  the  capital  stock  of  the  Company's
subsidiaries,  PetCARE TV,  African  American  Medical  Network,  and KidCARE TV
(collectively the  "Subsidiaries"),  pursuant to the terms of a Stock Pledge and
Escrow Agreement,  dated August 11, 2006. Repayment of the Note is guaranteed by
the Subsidiaries and is also secured by a blanket lien encumbering the assets of
the Company and the  Subsidiaries.  As an  inducement  for Vicis to purchase the
Note,  Philip M. Cohen,  President and Chief  Executive  Officer of the Company,
agreed to amend his employment agreement to include a three (3) year non-compete
clause.

NOTE E - COMMITMENTS AND CONTINGENCIES

On June 5, 2002,  the Company  entered into an Employment  Agreement  ("Original
Agreement")  with Philip Cohen.  On March 23, 2006,  the Original  Agreement was
replaced it its entirety with an Amended Employment Agreement ("Agreement") with
respect  to the  provision  of  services  as our  Chief  Executive  Officer  and
President. On August 11, 2006, as an inducement for Vicis Capital Master Fund to
loan the  Company  $1,302,000,  Mr.  Cohen  agreed to  execute a Second  Amended
Employment Agreement that added certain non-compete  provisions for a three-year
period following termination of the agreement.


                                       18
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 2006

NOTE E - COMMITMENTS AND CONTINGENCIES (Continued)

In August 2003, the Company  entered into a sixty-two (62) month lease agreement
commencing  on October 1, 2003 with Liberty  Property  Limited  Partnership  for
approximately  3,800  square  feet of  office/warehouse  space  located  at 8406
Benjamin Road,  Suite C, Tampa,  Florida 33634.  Under this  agreement,  minimum
lease expense for the 12 months ended  December 31, 2006 and 2007 and the eleven
months  ended  November  30, 2008 will be  approximately,  $40,300,  $41,100 and
$38,500 respectively.

At December 31, 2005,  the Company had a consulting  agreement in place with Mr.
James Calaway, a member of its Board of Directors. The agreement states that Mr.
Calaway provide financial consulting services,  at the direction of the Board of
Directors, for the amount of $667 per month.

On June 1, 2005, PetCARE TV entered into an employment agreement with Bernard J.
Kouma  with  respect  to the  provision  of  services  as its  President,  which
agreement  terminates  on May 31, 2010,  with a base salary of $72,000 per year.
The agreement also contains a two-year non-compete clause.

On  November  16,  2005,  African  American  Medical  Network  entered  into  an
employment  agreement  with Robert  Cambridge  with respect to the  provision of
services as its President, which agreement terminates on November 15, 2010, with
a base  salary of  $72,000  per year.  The  agreement  also  contains a two-year
non-compete clause.

On November 16, 2005,  the Company  entered into an  employment  agreement  with
Donald R. Mastropietro with respect to the provision of services as our Sr. Vice
President Finance, Chief Financial Officer,  Treasurer, and Assistant Secretary,
which agreement  terminates on November 15, 2010, with a base salary of $128,400
per year. The agreement also contains a two-year non-compete clause.

On November 16, 2005,  the Company  entered into an  employment  agreement  with
Charles V.  Richardson with respect to the provision of services as our Sr. Vice
President Marketing and Chief Marketing Officer,  which agreement  terminates on
March 31, 2009,  with a base salary of $150,000  per year.  The  agreement  also
contains a two-year non-compete clause.

On November 16, 2005,  the Company  entered into an  employment  agreement  with
Teresa J. Bray with respect to the  provision of services as our Vice  President
Administration/Compliance  and Secretary, which agreement terminates on November
15, 2010, with a base salary of $118,400 per year. The agreement also contains a
two-year non-compete clause.

On March 1, 2006, KidCARE TV entered into an employment agreement with Elaine K.
Mann with respect to the provision of services as its President, which agreement
terminates  on February  28, 2009,  with a base salary of $72,000 per year.  The
agreement also contains a two-year non-compete clause.

NOTE F - CONTRACTS

On January 1, 2006,  the Company  entered into a one-year  Consulting  Agreement
with Saddle Ranch  Productions,  Inc. ("Saddle Ranch"),  a Florida  corporation,
wherein Saddle Ranch will provide consulting services; specifically relating to:
(i) all areas of video  production,  editing,  and mastering;  (ii) all areas of
marketing,  specifically  related to  geographic  expansion  of the networks and
subscriber  base;  and (iii) all areas of advertising  sales,  including but not
limited to the employment of regional sales directors for the


                                       19
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 2006

NOTE F - CONTRACTS (Continued)

express  purpose  of  soliciting  and  obtaining  advertising  contracts  and/or
insertion  order for the  Company's  networks  with  concentration  on providing
product adjacencies and/or exclusivity for multi-network  purchases. The Company
will pay  Saddle  Ranch an  aggregate  of $19,000  per month for the  consulting
services.  On July 25, 2006,  the Consulting  Agreement  between the Company and
Saddle Ranch Productions, Inc. was amended to set out the monthly amount due for
services rendered under the contract as well as the addition of a commission for
advertising to be sold.

On January 3, 2006, PetCARE TV entered into a three-year  Distribution Agreement
with  Butler  Animal  Health  Supply  ("Butler  AHS")  granting  Butler  AHS the
exclusive  distribution  rights to sell PetCARE TV's veterinary client education
products (including annual subscriptions to the monthly DVD magazine and Welcome
Home Your New Friend DVDs) to veterinarian  hospitals  within the U.S. Butler is
the  nation's  largest  distributor  of  companion  animal  health  supplies  to
veterinarians.  Headquartered in Dublin,  Ohio,  Butler operates across the U.S.
with 15  distribution  centers  and 8  tele-centers.  Butler  serves over 29,000
veterinary  clinics in all 50 states and  distributes  over 15,000  products for
more than 300 vendors.

On March 13, 2006, PetCARE TV entered into a two-year Affinity Program Agreement
with American Animal Hospital  Association  ("AAHA") granting AAHA the exclusive
distribution  rights to sell PetCARE TV's veterinary  client education  products
(including  annual  subscriptions  to the monthly DVD  magazine and Welcome Home
Your New Friend  DVDs) to all AAHA member  hospitals  within the U.S.  There are
approximately 3,000 AAHA-accredited hospitals and AAHA will be promoting PetCARE
TV's client education programming as a value-added benefit to its membership.

NOTE G - SUBSEQUENT EVENTS

On July 25, 2006, the Consulting  Agreement between the Company and Saddle Ranch
Productions,  Inc.  dated  January 1, 2006,  was  amended to set out the monthly
amount due for services rendered under the contract as well as the addition of a
commission for advertising to be sold.

Effective  July 25, 2006,  by written  action  completed on August 7, 2006,  the
Company's  shareholders  owning  an  aggregate  of  52.6%  of the  total  shares
outstanding of the Company, voted to approve the Medical Media Television,  Inc.
2006 Equity Incentive Plan with an effective date of May 1, 2006.

On August 11, 2006, the Company issued a 10% Secured Convertible Promissory Note
in the principal  amount of $1,302,000  (the "Note")  pursuant to the terms of a
Note Purchase Agreement by and between the Company and Vicis Capital Master Fund
("Vicis").  The purchase  price paid for the Note was (a) $790,000 cash; (b) the
surrender  of two  secured  promissory  notes  each in the  principal  amount of
$50,000; and (c) the surrender of Series AA Convertible Debenture No. 05-0719 in
the  principal  amount of $412,000.  Repayment of the Note is  guaranteed by the
Company's  subsidiaries,  PetCARE TV,  African  American  Medical  Network,  and
KidCARE TV, and is also secured by a blanket lien  encumbering the assets of the
Company and its subsidiaries. In addition, as security for the Note, the Company
pledged all of the capital stock of its subsidiaries  pursuant to a Stock Pledge
and Escrow  Agreement  dated  August  11,  2006.  The Note  contains a number of
negative covenants  restricting the Company,  as discussed in more detail in the
Current  Report on Form 8-K filed with the  Securities  and Exchange  Commission
("SEC") on August 17, 2006.


                                       20
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 2006

NOTE G - SUBSEQUENT EVENTS

On August 11, 2006, as an  inducement  to Vicis to loan the Company  $1,302,000,
Philip M. Cohen, the Company's  President,  executed a Second Amended Employment
Agreement in which  non-compete  provisions  were added for a three-year  period
following the termination of the employment agreement.

Effective  August 11, 2006,  Randall Maxey resigned as a member of the Company's
Board of Directors.  The resignation  was not the result of a disagreement  with
the Company on any matter  relating to the Company's  operations,  policies,  or
practices.  The Board of Directors  has not yet appointed a new director to fill
the vacancy created by his resignation.


                                       21
<PAGE>

Item 2.          Management's Discussion and Analysis or Plan of Operation.

The following  discussion and analysis provides  information which management of
Medical Media Television, Inc. ("Medical Media" or the "Company") believes to be
relevant  to an  assessment  and  understanding  of  the  Company's  results  of
operations and financial condition. This discussion should be read together with
the Company's  financial  statements and the notes to the financial  statements,
which are  included  in this  report.  This  information  should also be read in
conjunction  with the information  contained in our Annual Report on Form 10-KSB
for the fiscal year ended  December 31, 2005,  including  the audited  financial
statements and notes included therein. Because of the nature of the Company as a
development  stage company,  the reported  results will not necessarily  reflect
future results of operations or financial condition.

Cautionary Statement Regarding Forward-Looking Statements

This Quarterly Report on Form 10-QSB contains "forward-looking  statements",  as
that term is defined in the Private  Securities  Litigation  Reform Act of 1995.
These statements  relate to future events or our future  financial  performance.
Some  discussions  in this report may contain  forward-looking  statements  that
involve  risk and  uncertainty.  A number of important  factors  could cause our
actual results to differ materially from those expressed in any  forward-looking
statements  made by us in this  report.  Forward-looking  statements  are  often
identified  by  words  like  "believe,"  "expect,"   "estimate,"   "anticipate,"
"intend,"  "project" and similar words or  expressions  which,  by their nature,
refer to future events.

In some cases, you can also identify  forward-looking  statements by terminology
such  as  "may,"  "will,"  "should,"   "plans,"   "predicts,"   "potential,"  or
"continue,"  or the  negative  of these terms or other  comparable  terminology.
These  statements  are only  predictions  and involve  known and unknown  risks,
uncertainties,  and other factors that may cause our actual  results,  levels of
activity, performance or achievements to be materially different from any future
results, levels of activity, performance or achievements expressed or implied by
these forward-looking statements.

Although  we believe  that the  expectations  reflected  in the  forward-looking
statements  are  reasonable,  we  cannot  guarantee  future  results,  levels of
activity,  or  achievements.  You  should  not place  undue  certainty  on these
forward-looking  statements,  which  apply  only as of the date of this  report.
These forward-looking  statements are subject to certain risks and uncertainties
that could cause actual results to differ materially from historical  results or
our predictions.  Except as required by applicable law, including the securities
laws of the United States, we do not intend to update any of the forward-looking
statements to conform these statements to actual results.

Overview

Medical  Media is a Florida  corporation  organized on October 2, 1989. We are a
development  stage company  focused on  developing,  establishing  and marketing
educational  programming for  distribution  on a monthly basis to  participating
subscribers  to our  veterinary  network,  our medical  network  directed to the
African  American  population,   and  our  pediatric  network.  Our  educational
programming is obtained through an annual  subscription and is funded,  in part,
by  commercial   advertisers  who  benefit  from  an  effective  and  convenient
advertising  medium to target their goods and services to the consumer patients.
Our goal is to be  recognized  as a  leading  provider  of  advertiser-supported
medical  education  programming  for patients and clients within the place-based
media environment of medical specialty offices nationwide.

We  provide   advertiser-supported   patient/parent/client   medical   education
programming  within the  place-based  media  environment  of  medical  specialty
offices  nationwide.  We have three  wholly-owned  operating  subsidiaries:  (1)
PetCARE  Television  Network,  Inc. ("PetCARE TV"), (2) African American Medical
Network,  Inc.  ("African  American Medical  Network");  and (3) KidCARE Medical
Television Network, Inc. ("KidCARE TV"). As discussed in more detail below, each
of our subsidiaries targets a different consumer base.


                                       22
<PAGE>

Medical  Media  produces  monthly  DVD  magazines  that are  distributed  to the
participating subscribers of PetCARE TV and African American Medical Network. We
plan to provide  monthly  updated  programming  for  KidCARE  TV through  either
monthly DVD  magazines  or through  direct video  streaming at each  subscribing
location. The programming is funded, in part, by commercial advertisers that are
reviewed and  approved by the  advisory  boards  serving  each  subsidiary.  Our
programming is obtained through an annual  subscription with updated programming
provided directly to the subscribers.

PetCARE TV

PetCARE TV's goal is to provide  animal health and welfare  education to a large
number of  consumers of pet  products  and  services  while  serving as a unique
advertising  medium for  companies  that market  those goods and  services.  Our
educational  programming is currently aired in veterinary  practices  across the
U.S.,  Canada,  Puerto Rico, and Australia  where it is viewed by an estimated 4
million  pet owners each  month.  Each month  PetCARE TV provides an updated DVD
magazine focused on optimal  healthcare for animal  companions.  PetCARE TV also
sells an instructional  DVD to veterinarians  for them to give to their clients,
entitled "Welcome Home Your New Friend".

African American Medical Network

African American Medical Network's goal is to provide educational programming to
doctor's offices nationwide serving African American patients, and to provide an
advertising medium for commercial advertisers to target their goods and services
to these consumer  patients.  Our educational  programming is currently aired in
hundreds of physician offices across the U.S. and is targeted to the patients of
the more than  15,000  doctors  who serve the  majority  of the 35 million  U.S.
African Americans.

KidCARE TV

KidCARE TV will target parent consumers in pediatric  waiting rooms  nationwide.
KidCARE  TV is not yet  operational,  but  plans to  establish  a  collaborative
interaction with the viewing audience through its short  informational  segments
developed to create  awareness about  preventative  health  measurers along with
specific  childhood  illnesses  and  issues.  These  segments  are  designed  to
stimulate  the  viewer  to  seek  further  guidance  from  their   pediatrician.
Interspersed   throughout   the   segments,   promotional   pieces  will  appear
demonstrating  related  health  care  items.  KidCARE  TV's  primary  target for
subscribership will be members of the American Academy of Pediatrics.

Additional  information  about  our  Company  and  each  of  the  aforementioned
subsidiaries  is  available  at the  following  websites,  which we developed in
cooperation   with  third-party   consultants:   www.medicalmediatelevision.com,
www.petcaretv.com, www.africanamericanmedicalnetwork.com, and www.kidcaretv.com.
These  websites  serve  primarily  as  an  informational  tool  for  prospective
subscribers and advertisers,  who can log on to find out more about our business
and the goods and services that we provide.  Prospective subscribers are allowed
to view samples of our current  programming,  review frequently asked questions,
review our subscription process, and print out a subscription agreement.

We have expended  approximately  $6,250,000  through June 30, 2006 in developing
our  business  plan.  For the  period  from the  implementation  of our  current
business plan (June 2002) through June 30, 2006,  we have  generated  revenue of
$274,953  from  advertising  and  $60,362  from  sales of our  educational  DVD,
"Welcome Home Your New Friend," distributed by our PetCARE TV subsidiary. During
the  same  period,  we  also  generated  revenue  from  subscription   sales  to
veterinarian  offices of  $88,487  of which  $41,146  is  recorded  as  deferred
revenue.


                                       23
<PAGE>

Development Stage Company; Prior Going Concern Issue

We currently are a development stage company under the provisions of SFAS No. 7,
and have  negative  cash  flows from  operations  and no  established  source of
revenue.  We do not anticipate  significant  revenues from advertising  sales or
subscription sales until the fourth quarter of 2006. The foregoing matters raise
substantial  doubt  about the  ability  of our  Company to  continue  as a going
concern;  however,  as a result of a financing recently completed in August 2006
in which the Company  received  total cash proceeds of $790,000 and  anticipated
revenues,  management  now believes  that the  Company's  cash on hand and funds
generated from operations will be sufficient to fund its ongoing  operations for
the next twelve  months.  Management  believes  the current  cash on hand or its
anticipated  revenues  may not be  sufficient  to retire the full  amount of the
obligations described in the section entitled "Liquidity and Capital Resources,"
that  mature  during the next  twelve  months.  As such,  the  Company  may seek
external  sources to satisfy these  obligations.  Failure to obtain such funding
would have a material adverse effect on the Company's  results of operations and
financial condition.

Our plan of operation  for the  twelve-month  period  following the date of this
Quarterly  Report on Form  10-QSB is to  continue  to  develop  and  market  our
educational programming.  We currently do not have any plans to purchase or sell
any  significant  equipment,  nor do we  currently  anticipate  any  significant
changes in the number of employees. We do not own any real property.

Recent Events

On August 11, 2006, the Company issued a 10% Secured Convertible Promissory Note
in the principal  amount of $1,302,000  (the "Note")  pursuant to the terms of a
Note Purchase Agreement by and between the Company and Vicis Capital Master Fund
("Vicis").  The purchase  price paid for the Note was (a) $790,000 cash; (b) the
surrender  of two  secured  promissory  notes  each in the  principal  amount of
$50,000; and (c) the surrender of Series AA Convertible Debenture No. 05-0719 in
the  principal  amount of $412,000.  Repayment of the Note is  guaranteed by the
Company's  subsidiaries,  PetCARE TV,  African  American  Medical  Network,  and
KidCARE TV, and is also secured by a blanket lien  encumbering the assets of the
Company and its subsidiaries. In addition, as security for the Note, the Company
pledged all of the capital stock of its subsidiaries  pursuant to a Stock Pledge
and Escrow  Agreement  dated  August  11,  2006.  The Note  contains a number of
negative covenants  restricting the Company,  as discussed in more detail in the
Current  Report on Form 8-K filed with the  Securities  and Exchange  Commission
("SEC") on August 17, 2006.

On August 11, 2006, as an  inducement  to Vicis to loan the Company  $1,302,000,
Philip M. Cohen, the Company's  President,  executed a Second Amended Employment
Agreement in which  non-compete  provisions  were added for a three-year  period
following the termination of the employment agreement.

Effective  August 11, 2006,  Randall Maxey resigned as a member of the Company's
Board of Directors.  The resignation  was not the result of a disagreement  with
the Company on any matter  relating to the Company's  operations,  policies,  or
practices.  The Board of Directors  has not yet appointed a new director to fill
the vacancy created by his resignation.

On July 25, 2006, the Consulting  Agreement between the Company and Saddle Ranch
Productions,  Inc.  dated  January 1, 2006,  was  amended to set out the monthly
amount due for services rendered under the contract as well as the addition of a
commission for advertising to be sold.


                                       24
<PAGE>

Effective  July 25, 2006,  by written  action  completed on August 7, 2006,  the
Company's  shareholders  owning  an  aggregate  of  52.6%  of the  total  shares
outstanding of the Company, voted to approve the Medical Media Television,  Inc.
2006 Equity Incentive Plan with an effective date of May 1, 2006.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements.

Critical Accounting Policies and Estimates

Our  financial  statements  have been  prepared in  accordance  with  accounting
principles  generally  accepted in the United States.  The  preparation of these
financial  statements  requires us to make  significant  estimates and judgments
that affect the reported amounts of assets, liabilities,  revenues, expenses and
related  disclosure  of  contingent  assets and  liabilities.  We  evaluate  our
estimates,  including  those related to  contingencies,  on an ongoing basis. We
base our estimates on  historical  experience  and on various other  assumptions
that are believed to be reasonable under the circumstances, the results of which
form the basis for  making  judgments  about the  carrying  values of assets and
liabilities that are not readily apparent from other sources. Actual results may
differ from these estimates under different assumptions or conditions.

Revenue Recognition

The Company generates revenue from three primary sources,  namely advertisers on
its  DVD  magazines  (the  "Advertisers"),  subscribers  to  its  networks  (the
"Subscribers"),  and the sale of our  instructional  DVD,  Welcome Home Your New
Friend.  With regard to  Advertisers,  the Company  recognizes  revenue over the
periods in which the advertisers'  commercials appear on its DVD magazine.  With
regard to Subscribers,  revenue is recognized proportionately over the length of
the  subscription  agreement  entered  into by the  Subscribers.  With regard to
Welcome Home Your New Friend,  revenue is  recognized in the period the DVDs are
shipped.

Results of Operations

The following  discussion  and analysis sets forth the major factors that affect
the Company's  results of operations  and financial  condition  reflected in the
unaudited  financial  statements for the three-month  period ended June 30, 2006
and the  six-month  period ended June 30,  2006.  This  discussion  and analysis
should be read in  conjunction  with the  information  contained  in our  Annual
Report on Form 10-KSB for the fiscal year ended December 31, 2005, including the
audited financial statements and footnotes included therein.

Results of Operations - Inception (October 2, 1989) to June 30, 2006

From  inception to June 30, 2006, we had losses  totaling  $8,015,450.  For this
period, our general and administrative  costs totaled $3,879,036 or 54% of total
operating  expenses.  DVD  production  costs  totaled  $660,100  or 9% of  total
operating  expenses,  and sales and marketing costs totaled $2,450,420 or 34% of
total operating  expenses.  The remainder of operating expense is represented by
depreciation  and  amortization  that totaled  $198,979 or 3% of total operating
expenses.

Results of Operations - Comparison of Six Months Ending June 30, 2006 and 2005

For  the  six-month  period  ending  June  30,  2006,  we  had  losses  totaling
$1,478,160,  compared to losses of $960,945 for the same period in 2005. This is
an increase of $517,215.  During the six-month  period ending June 30, 2006, our
general and  administration  costs totaled $610,376 compared to $414,467 for the
same period in 2005,  which is  primarily a result of: (i) costs  related to our
registration  statement  on Form  SB-2  filed  during  the first  quarter,  (ii)


                                       25
<PAGE>

placement fees related to the Quiros November Note and the CapitalSmart  funding
during  the first  quarter,  and (iii)  administrative  expenses  related to the
operation of African American Medical Network that we acquired in November 2005.
Our DVD production  costs totaled  $136,034 for the period ending June 30, 2006,
compared to $77,123 for the same  period in 2005.  This  increase is a result of
additional  production efforts related to African American Medical Network.  Our
sales and marketing  costs  totaled  $618,734 for the six months ending June 30,
2006,  compared to  $191,027  for the same  period in 2005.  This  increase is a
result of increased  sales and marketing  efforts  related to PetCARE TV and the
addition of African  American  Medical  Network.  Depreciation  and amortization
costs  totaled  $43,243 for the six months ended June 30, 2006,  which  includes
amortization of certain intangible assets acquired in the acquisition of African
American Medical Network.

Results of Operations - Comparison of Three Months Ending June 30, 2006 and 2005

For the  three-month  period  ending  June  30,  2006,  we had  losses  totaling
$604,984, compared to losses of $494,029 for the same period in 2005. This is an
increase of $110,955.  During the  three-month  period ending June 30, 2006, our
general and  administration  costs totaled $230,001 compared to $241,897 for the
same period in 2005,  which is  primarily a result of: (i) costs  related to our
registration  statement  on Form  SB-2  filed  during  the first  quarter,  (ii)
placement fees related to the Quiros November Note and the CapitalSmart  funding
during  the first  quarter,  and (iii)  administrative  expenses  related to the
operation of African American Medical Network that we acquired in November 2005.
Our DVD  production  costs totaled  $74,004 for the period ending June 30, 2006,
compared to $40,604 for the same  period in 2005.  This  increase is a result of
additional  production efforts related to African American Medical Network.  Our
sales and marketing costs totaled  $256,165 for the three months ending June 30,
2006, compared to $70,617 for the same period in 2005. This increase is a result
of increased sales and marketing  efforts related to PetCARE TV and the addition
of African American Medical Network. Depreciation and amortization costs totaled
$21,587 for the three months ended June 30, 2006, which includes amortization of
certain  intangible  assets  acquired  in the  acquisition  of African  American
Medical Network.

Liquidity and Capital Resources

We have  approximately  $754,000  of cash on hand as of August  11,  2006.  As a
result of a  financing  recently  completed  in August 2006 in which the Company
received total cash proceeds of $790,000 and  anticipated  revenues,  management
now believes that the Company's cash on hand and funds generated from operations
will be sufficient to fund its ongoing  operations  for the next twelve  months.
Management believes the current cash on hand or its anticipated revenues may not
be  sufficient  to retire the full amount of the  obligations  described  in the
section entitled  "Liquidity and Capital Resources," that mature during the next
twelve months.  As such, the Company may seek external  sources to satisfy these
obligations. Failure to obtain such funding would have a material adverse effect
on the Company's results of operations and financial condition.

On May 16,  2002,  we issued a  non-interest  bearing  promissory  note to James
Calaway, a shareholder and former director,  in the original principal amount of
$100,000 (the "Calaway  Note").  At June 30, 2006, the principal  balance due on
the Calaway Note was $61,000.

In  June  2002,  we  issued  the  following  shareholders  non-interest  bearing
promissory  notes  (the  "Hugo/Turner  Notes"),  all of which  remained  due and
payable at June 30, 2006:

      o     Daniel V. Hugo, a former officer/director, in the amount of $16,668;
      o     Robert and Janna Hugo, in the amount of $4,000; and
      o     Robert and Jamie Turner, in the amount of $3,332.


                                       26
<PAGE>

On May 6, 2005,  the Company  issued to Vicis  Capital  Master Fund  ("Vicis") a
Series B Convertible  Debenture  (the  "Debenture")  in the principal  amount of
$250,000,  and  related  Series D, Series E and Series F Common  Stock  Purchase
Warrants.  The Debenture has a term of 24 months and accrues  interest an annual
rate of fifteen  percent  (15%).  The Company has the option to pay  interest in
cash or in shares of its registered common stock at a ten percent (10%) discount
to the  market  price,  as  calculated  pursuant  to the  express  terms  of the
Debenture.  At  maturity,  Vicis may  convert the  Debenture  into shares of the
Company's  Common Stock at a price of $2.40 per share.  On October 19, 2005, the
conversion  price was reduced to $0.166  pursuant to the extension  terms of the
Series AA Convertible Debenture described in further detail below.

On November 16, 2005, the Company issued Series AA Convertible Debenture, Series
AA Common Stock Purchase Warrants,  and Series BB Common Stock Purchase Warrants
to Vicis.  Pursuant to the terms of the Series AA Convertible  Debenture,  Vicis
loaned the  Company an  aggregate  of  $412,000 at an annual rate of interest of
sixteen  percent  (16%).  The Series AA  Convertible  Debenture was cancelled on
August 11, 2006 and the principal  amount due  thereunder,  plus all accrued and
unpaid interest  through August 11, 2006,  became part of a Secured  Convertible
Promissory Note dated August 11, 2006 in the amount of $1,302,000.  The terms of
the Secured Convertible Promissory Note are described in detail below.

On November  16,  2005,  the Company  issued a  Promissory  Note for $100,000 to
Laurence Wallace (the "Wallace  Promissory  Note").  The Wallace Promissory Note
accrues  interest at an annual rate of eight  percent (8%). On the maturity date
of the  Wallace  Promissory  Note,  Wallace  has the  option  to  execute a debt
conversion  agreement under which the principal amount of the Wallace Promissory
Note will be converted into 100,000 units of the Company's securities, each unit
consisting of (i) two shares of Medical  Media's  Common Stock (for an aggregate
of 200,000  shares),  and (ii) one Common Stock Purchase  Warrant to purchase an
additional  share of Medical  Media's  Common Stock (for an aggregate of 100,000
warrants) with an exercise price of $1.00 per share. The Wallace Promissory Note
was due on April 17,  2006.  The  Company is in the  process of  negotiating  an
extension of the Maturity  Date,  however,  the Company may be  unsuccessful  in
negotiating such an extension.

On November  16,  2005,  the Company  issued a  Promissory  Note for $200,000 to
Carmen Bernstein (the "Bernstein  Promissory  Note").  The Bernstein  Promissory
Note accrues  interest at an annual rate of ten percent  (10%).  On the maturity
date of the  Bernstein  Promissory  Note,  Bernstein has the option to execute a
debt  conversion  agreement  under which the  principal  amount of the Bernstein
Promissory   Note  will  be  converted  into  200,000  units  of  the  Company's
securities,  each unit consisting of (i) one share of the Medical Media's common
stock (for an aggregate of 200,000 shares),  and (ii) one warrant to purchase an
additional  share of Medical  Media's  common stock (for an aggregate of 200,000
warrants)  with an exercise price of $2.00 per share.  The Bernstein  Promissory
Note was due on December 14, 2005,  and, as of the date of this filing,  has not
been  repaid  although  it has  been  extended  indefinitely  by  mutual  verbal
agreement.

On  November  30,  2005,  the  Company  issued to William  H.  Quiros a 12-month
Convertible  Promissory  Note  ("November  Quiros  Note")  for  $1,000,000  with
interest  accruing  at the rate of twenty  percent  (20%) per annum,  compounded
semi-annually.  Interest was to be paid at the end of each  calendar  quarter in
either shares of Series C Zero Coupon  Preferred  Stock of the Company valued at
$1.00 per share,  or cash,  at the option of  Quiros.  The Series C Zero  Coupon
Preferred  Stock would convert into shares of the Company's  Common Stock on the
maturity date of the November Quiros Note at a ten percent (10%) discount to the
then-current market price based on the average closing price for the twenty (20)
days  immediately  preceding  the  conversion.  On December 31, 2005 the Company
issued 8,627 shares of its Series C Zero Coupon  Preferred  Stock as payment for
$8,627  interest  accrued  through  December  31,  2005.  The 8,627  shares  are
convertible into 9,586 shares of the Company's Common Stock. At maturity, Quiros
had the option to convert the  November  Quiros  Note into  Common  Stock of the
Company at a fixed  conversion  price of $.40 per share. The Company also issued
Quiros five-year Common Stock Purchase Warrants ("Quiros  Warrants") to purchase


                                       27
<PAGE>

an aggregate of 2,500,000  shares of common stock at a Fixed  Exercise  price of
$0.75 per share.  On July 28, 2006,  the Company and Quiros  agreed to amend the
terms of the November Quiros Note as follows: (i) the Maturity Date was extended
to November 30, 2008; (ii) the note would not be convertible  until the Maturity
Date;  (iii) the  Company  would  have the  option to repay the note at any time
prior to the Maturity Date; (iv) the conversion price on the note was changed to
an amount equal to a twenty  percent (20%) discount to the  then-current  market
price based on the average  closing  price for the twenty (20) days  immediately
preceding  the  conversion,  but in no event less than  $0.166  per  share;  (v)
quarterly  interest  payments  on the note would be applied  toward the  balance
remaining  unpaid  under the March Quiros Note (as  described  below) until such
time as the entire $450,000 under the March Quiros Note has been received by the
Company,  at which time all future interest will accrue, but will not become due
and payable  until the maturity  date;  and (vi)  certain  price  ratchets  were
deleted.  The November Quiros Warrants were also amended to delete certain price
ratchets.  The November Quiros Note and the  accompanying  Common Stock Purchase
Warrants are not  convertible  or exercisable  such that Quiros'  overall Common
Stock ownership position in the Company exceeds 4.99%;  provided,  however, that
upon Quiros  providing the Company with  sixty-one (61) days notice (the "Waiver
Notice") that he would like to waive this  restriction with regard to any or all
shares of Common Stock issuable upon exercise of the  conversion  feature of the
November Quiros Note, this restriction will be of no force or effect with regard
to all or a portion of the November Quiros Note referenced in the Waiver Notice,
and provided  further that this provision shall be of no further force or effect
during the sixty-one (61) days immediately  preceding the expiration of the term
of the November Quiros Note.

On January 27, 2006,  the Company and  CapitalSmart,  LLC, a California  limited
liability  corporation,  ("CSmart")  entered  into  a  Note  Purchase  Agreement
pursuant to which CSmart  agreed to loan the Company an aggregate of  $1,000,000
through  installments of $250,000 on February 15, 2006 and $750,000 on March 31,
2006. As of July 28, 2006, Csmart had loaned the Company  $624,580.50.  The Note
Purchase  Agreement  provided  that  the  Company  issue  Csmart  a  convertible
promissory  note in the  original  aggregate  face  amount  of  $1,000,000  (the
"CapitalSmart  Note") and five-year  Common Stock Purchase  Warrants to purchase
2,500,000  shares of the  Company's  Common Stock (the "CSmart  Warrants")  at a
Fixed Exercise  Price of $0.75 per share.  The Company has issued CSmart 625,000
Warrants.  Pursuant  to the terms of the Note  Purchase  Agreement,  the Company
issued the CSmart  Note on  February  15,  2006.  The CSmart  Note was to mature
twelve  months  from the date of  issuance  (the  "Maturity  Date") and  accrued
interest at a rate of 20%  (compounded  semi-annually).  Interest was payable at
the end of each  quarter  in either (i)  shares of the  Company's  Series C Zero
Coupon  Preferred Stock valued a $1.00 per share, or (ii) cash, at the option of
CSmart.  The first interest  payment due on March 31, 2006 of $6,438 was paid on
April 1, 2006. On the Maturity Date, CSmart had the option to convert the CSmart
Note into shares of the Company's  Common Stock at a fixed  conversion  price of
$0.40 per share.  On July 28, 2006,  CSmart and the Company agreed to cancel the
Csmart Note and the outstanding  625,000 CSmart  Warrants,  and to issue in lieu
thereof,  separate replacement  convertible promissory notes and warrants to the
principals of CSmart or to entities  controlled by the principals of CSmart.  In
accordance therewith,  four convertible  promissory notes in an aggregate amount
equal to $1 million were issued to: Softrev Partners, Inc. for $250,000, Gilbert
B. Ross for  $200,000,  William H.  Quiros  for  $450,000,  and Steven  Port for
$100,000.  The notes,  described in detail herein,  were issued on July 28, 2006
with an  effective  date as to when  each  principal  contributed  funds  to the
Company to be applied toward the CSmart note balance.

On February 15, 2006, the Company issued a Convertible Promissory Note to Steven
J. Port for  $100,000  (the  "February  Port Note") and  five-year  Common Stock
Purchase  Warrants to purchase 250,000 shares of the Company's Common Stock at a
Fixed Conversion  Price of $0.75 per share (the "February Port  Warrants").  The
February Port Note was issued as a partial  replacement  for the CSmart Note for
$1,000,000  described  above.  The February  Port Note will mature twelve months


                                       28
<PAGE>

from the date of issuance (the "Maturity Date") and accrues interest at the rate
of 20% compounded semi-annually. At the option of Port, interest will be paid at
the end of each  quarter  in either (i)  shares of the  Company's  Series C Zero
Coupon  Preferred Stock valued a $1.00 per share, or (ii) cash. The Port Note is
not be convertible until the Maturity Date. With the consent of both the Company
and Port,  the February  Port Note may be extended for an  additional  12 months
with the terms of the  interest  payments  remaining  the same.  On the Maturity
Date,  Port has the option to convert the February  Port Note into shares of the
Company's  Common  Stock at a price equal to forty cents  ($0.40),  or an amount
equal to a twenty percent (20%) discount to the then-current  market price based
on the average closing price for the twenty (20) days immediately  preceding the
conversion, with the exception that the Conversion Price shall not be lower than
$0.166.

On February  16,  2006,  the Company  issued a  Convertible  Promissory  Note to
Gilbert B. Ross for  $200,000  (the  "Ross  Note") and  five-year  Common  Stock
Purchase  Warrants to purchase 500,000 shares of the Company's Common Stock at a
Fixed Conversion Price of $0.75 per share (the "Ross  Warrants").  The Ross Note
was issued as a partial replacement for the CSmart Note for $1,000,000 described
above.  The Ross Note will mature  three  years from the date of  issuance  (the
"Maturity  Date") and accrues  interest at the rate of twenty  percent (20%) per
annum.  Interest accrues but is not due and payable until the Maturity Date. The
Ross Note is not  convertible  until the Maturity Date. With the consent of both
the Company and Ross,  the Ross Note may be extended for an additional  12-month
term,  with the  terms of the  interest  payments  remaining  the  same.  On the
Maturity  Date,  Ross has the option to convert the Ross Note into shares of the
Company's  Common Stock at a price equal to a twenty  percent (20%)  discount to
the then-current  market price based on the average closing price for the twenty
(20)  days  immediately  preceding  the  conversion,  but in no event  shall the
Conversion Price be less than $0.166 per share.

On March 31, 2006, the Company issued a Convertible  Promissory  Note to William
H. Quiros for $450,000 (the "March  Quiros Note") and agreed to issue  five-year
Common Stock  Purchase  Warrants to purchase  1,125,000  shares of the Company's
Common Stock at a Fixed  Conversion  Price of $0.75 per share (the "March Quiros
Warrants").  The March Quiros Note was issued as a partial  replacement  for the
CSmart Note for $1,000,000  described  above.  The March Quiros Note will mature
three years from the date of issuance (the "Maturity Date") and accrues interest
at a rate of twenty percent (20%) per annum. Interest accrues but is not due and
payable until the Maturity Date. The March Quiros Note not convertible until the
Maturity Date. With the consent of both the Company and Quiros, the March Quiros
Note may be extended  for an  additional  12-month  term,  with the terms of the
interest  payments  remaining  the same.  On the Maturity  Date,  Quiros has the
option to convert  the March  Quiros Note into  shares of the  Company's  Common
Stock at a price equal to a twenty  percent (20%)  discount to the  then-current
market  price  based on the  average  closing  price  for the  twenty  (20) days
immediately preceding the conversion, but in no event shall the Conversion Price
be less than $0.166 per share.

On March 31, 2006, the Company issued a Convertible Promissory Note to Elaine G.
Edinburg for $10,000 (the "Edinburg  Note") and five-year  Common Stock Purchase
Warrants to purchase  25,000  shares of the  Company's  Common  Stock at a Fixed
Conversion Price of $0.75 per share (the "Edinburg Warrants"). The Edinburg Note
matures  twelve  months  from the date of  issuance  (the  "Maturity  Date") and
accrues interest at a rate of twenty percent (20%) compounded semi-annually.  At
the  option of  Edinburg,  interest  will be paid at the end of each  quarter in
either (i) shares of the Company's Series C Zero Coupon Preferred Stock valued a
$1.00 per share, or (ii) cash. On the Maturity Date,  Edinburg had the option to
convert the Edinburg Note into shares of the  Company's  Common Stock at a Fixed


                                       29
<PAGE>

Conversion  Price of $0.40 per share.  With the  consent of both the Company and
Edinburg, the Edinburg Note may be extended for an additional twelve (12) months
with the terms of the interest  payments  remaining  the same. On June 20, 2006,
Edinburg and the Company agreed to amend the Edinburg Note and Edinburg Warrants
as follows:  (i) the conversion price was changed to the Investor's option of an
amount equal to forty cents ($0.40) or an amount equal to a twenty percent (20%)
discount to the then-current market price based on the average closing price for
the twenty (20) days  immediately  preceding the conversion,  with the exception
that the  Conversion  Price  shall  not be lower  than  $0.166;  and (ii)  price
ratchets were deleted.

On April 1, 2006, the Company issued a Convertible  Promissory Note to Steven J.
Port for $125,000  made in  installments  (the "April Port Note") and  five-year
Common  Stock  Purchase  Warrants to purchase  312,500  shares of the  Company's
Common  Stock at a Fixed  Conversion  Price of $0.75 per share (the  "April Port
Warrants"). The original maturity date of the April Port Note was April 30, 2006
and interest  accrues at the rate of twenty  percent  (20%) per annum.  Interest
accrues, but is not due and payable until the Maturity Date. The April Port Note
automatically extends to the end of each succeeding month until such time as the
Port  provides a 15-day  written  notice to the Company that the April Port Note
may no longer be automatically  extended.  The terms of interest will remain the
same throughout the automatic  extension periods. On the Maturity Date, Port has
the option to convert  the April Port Note into shares of the  Company's  Common
Stock at a price equal to an amount equal to forty cents  ($0.40),  or an amount
equal to a twenty percent (20%) discount to the then-current  market price based
on the average closing price for the twenty (20) days immediately  preceding the
conversion, with the exception that the Conversion Price shall not be lower than
$0.166.

On April 16, 2006, the Company issued a Convertible  Promissory  Note to Softrev
Partners,  Inc. for $250,000  (the "Softrev  Note") and  five-year  Common Stock
Purchase  Warrants to purchase 625,000 shares of the Company's Common Stock at a
Fixed Conversion Price of $0.75 per share (the "Softrev Warrants").  The Softrev
Note was  issued as a partial  replacement  for the CSmart  Note for  $1,000,000
described  above. The Softrev Note matures three years from the date of issuance
(the "Maturity Date") and accrues interest at a rate of twenty percent (20%) per
annum.  Interest accrues but is not due and payable until the Maturity Date. The
Softrev Note shall not be convertible  until the Maturity Date. With the consent
of both the  Company  and  Softrev,  the  Softrev  Note may be  extended  for an
additional  12-month term, with the terms of the interest payments remaining the
same. On the Maturity  Date,  Softrev has the option to convert the Softrev Note
into shares of the Company's  Common Stock at a price equal to a twenty  percent
(20%)  discount to the  then-current  market price based on the average  closing
price for the twenty (20) days immediately  preceding the conversion,  but in no
event shall the Conversion Price be less than $0.166 per share.

On June 1,  2006,  the  Company  issued a Secured  Promissory  Note to Vicis for
$50,000  ("Vicis  June 1 Secured  Note").  The Vicis June 1 Secured  Note was to
mature on December 31, 2006 and accrued  interest at a rate of eighteen  percent
(18%) per annum.  The Vicis  June 1 Secured  Note was  secured  by all  accounts
receivable due from Butler Animal Health Supply after June 1, 2006, or any other
money due the Company from any and all other  sources.  The Vicis June 1 Secured
Note could be prepaid in whole or in part at any time, with a prepayment penalty
of $5,492.25.  On August 11, 2006,  Vicis  surrendered  the Vicis June 1 Secured
Note  as  partial   consideration  for  the  Company's  issuance  of  a  Secured
Convertible Promissory Note in the principal amount of $1,302,000.

On June 30,  2006,  the Company  issued a Secured  Promissory  Note to Vicis for
$50,000  ("Vicis June 30 Secured  Note").  The Vicis June 30 Secured Note was to
mature on January 31, 2007 and  accrued  interest at a rate of eighteen  percent
(18%) per  annum.  The Vicis June 30 Secured  Note was  secured by all  accounts
receivable  due from Butler  Animal  Health  Supply after June 30, 2006,  or any
other money due the Company  from any and all other  sources.  The Vicis June 30
Secured Note could be prepaid in whole or in part at any time, with a prepayment
penalty of $5,492.25.  On August 11, 2006,  Vicis  surrendered the Vicis June 30
Secured Note as partial  consideration  for the Company's  issuance of a Secured
Convertible Promissory Note in the principal amount of $1,302,000.


                                       30
<PAGE>

On August 11, 2006, the Company issued a 10% Secured Convertible Promissory Note
in the  principal  amount of  $1,302,000  (the "Note") to Vicis  pursuant to the
terms of that certain Note Purchase Agreement (the "Purchase Agreement") of even
date therewith.  As consideration for the Note, Vicis (a) delivered  $790,000 in
cash (the "Cash Payment");  (b) surrendered two secured  promissory notes issued
by the Company to Vicis on June 1, 2006, and June 30, 2006,  respectively,  each
in the principal  amount of $50,000  (collectively,  the "June Notes");  and (c)
surrendered a Series AA Convertible  Debenture No. 05-0719 issued by the Company
to  Vicis  on  July  19,  2005,  in  the  principal   amount  of  $412,000  (the
"Debenture"). At any time while the Note remains outstanding,  Vicis may convert
the  outstanding  principal  balance and any accrued but unpaid  interest on the
Note into shares of the Company's common stock, par value $.0005 per share, at a
conversion  price of $.166 per share (the  "Conversion  Shares").  The principal
balance of the Note is due,  in one lump sum  payment,  on August 10,  2007 (the
"Maturity Date"),  unless earlier converted.  Interest on such principal (or any
balance  thereof  outstanding  from time to time)  accrues at an annual  rate of
interest of ten percent (10%). As so accrued,  interest shall be due and payable
to Vicis on the Maturity  Date. If the Company  commits any Event of Default (as
defined in the Purchase  Agreement),  then the unpaid  principal  amount of, and
accrued  interest  on, the Note may be  accelerated  by Vicis and become due and
payable,  whereupon  the  interest  rate shall be  increased to a rate of twenty
percent  (20%) per annum,  subject to the  limitations  of  applicable  law.  As
security for the  Company's  obligations  under the Purchase  Agreement  and the
Note,   the  Company   pledged  all  of  the  capital  stock  of  the  Company's
subsidiaries,  PetCARE TV,  African  American  Medical  Network,  and KidCARE TV
(collectively the  "Subsidiaries"),  pursuant to the terms of a Stock Pledge and
Escrow Agreement,  dated August 11, 2006. Repayment of the Note is guaranteed by
the Subsidiaries and is also secured by a blanket lien encumbering the assets of
the Company and the  Subsidiaries.  In addition to the  foregoing,  the Purchase
Agreement contains negative covenants restricting the Company's activities while
the Note remains outstanding,  as discussed in more detail in the Current Report
on Form 8-K filed with the SEC on August 17, 2006. As an inducement for Vicis to
purchase the Note, Philip M. Cohen, President and Chief Executive Officer of the
Company,  agreed to amend his  employment  agreement to include a three (3) year
non-compete clause.

From  inception   through  June  30,  2006,  we  incurred  interest  expense  of
$1,127,022.   This  amount  includes  accrued  interest  totaling  approximately
$104,735 related to the Capital Smart Note, the Series B Convertible  Debenture,
the Vicis $412,000 Note, and the Bernstein and Wallace Promissory Notes. It also
includes  (i) a  $250,000  non-cash  payment of  interest  related to the Victus
February  Note (in May 2004,  we issued  11,905  shares of our  Common  Stock at
$21.00 per share and 23,810 Common Stock  Purchase  Warrants in lieu of $250,000
in interest due), (ii) a $307,044  payment of interest related to the Edge Notes
(which was paid through the  issuance of 307,044  shares of Series A Zero Coupon
Preferred  Stock),  (iii) a $312,329  payment of  interest  related to the Vicis
Debentures  and  Maltzer  Note (which was paid  through the  issuance of 312,239
shares of Series B Zero Coupon  Preferred  Stock),  and (iv) a $8,627 payment of
interest  related to the  Quiros  November  Note  (which  was paid  through  the
issuance of 8,627 shares of Series C Zero Coupon  Preferred  Stock),  and (v) an
additional $144,287 in interest paid.

If we do not generate  revenues or secure debt or equity  financing,  we will be
unable to pay one or more of the obligations referenced above.


                                       31
<PAGE>

Item 3.           Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this report,  the Company  carried out an
evaluation,  under the supervision and with the  participation  of the Company's
Principal Executive Officer and Principal Financial Officer of the effectiveness
of the design and operation of the Company's disclosure controls and procedures.
The Company's  disclosure  controls and  procedures  are designed to ensure that
information  required  to be  disclosed  by us in the  reports we file or submit
under the Exchange Act is recorded,  processed,  summarized and reported, within
the time periods specified in the SEC's rules and forms. The Company's Principal
Executive  Officer and  Principal  Financial  Officer  have  concluded  that the
Company's  disclosure  controls and procedures  are, in fact,  effective at this
reasonable assurance level as of the period covered.

Changes in Internal Controls over Financial Reporting

In connection with the evaluation of the Company's  internal controls during the
Company's quarter ended June 30, 2006, the Company's Principal Executive Officer
and Principal Financial Officer have determined that there are no changes to the
Company's  internal  controls  over  financial  reporting  that have  materially
affected,  or are reasonably likely to materially effect, the Company's internal
controls over financial reporting.

PART II - OTHER INFORMATION

Item 1.           Legal Proceedings.

None.

Item 2.           Unregistered Sales of Equity Securities and Use of Proceeds.

Unregistered Sales of Equity Securities

On March 31, 2006, the Company issued a Convertible Promissory Note to Elaine G.
Edinburg for $10,000 (the "Edinburg  Note") and five-year  Common Stock Purchase
Warrants to purchase  25,000  shares of the  Company's  Common  Stock at a Fixed
Conversion Price of $0.75 per share (the "Edinburg Warrants"). The Edinburg Note
matures  twelve  months  from the date of  issuance  (the  "Maturity  Date") and
accrues interest at a rate of twenty percent (20%) compounded semi-annually.  At
the  option of  Edinburg,  interest  will be paid at the end of each  quarter in
either (i) shares of the Company's Series C Zero Coupon Preferred Stock valued a
$1.00 per share, or (ii) cash. On the Maturity Date,  Edinburg had the option to
convert the Edinburg Note into shares of the  Company's  Common Stock at a Fixed
Conversion  Price of $0.40 per share.  With the  consent of both the Company and
Edinburg, the Edinburg Note may be extended for an additional twelve (12) months
with the terms of the interest  payments  remaining  the same. On June 20, 2006,
Edinburg and the Company agreed to amend the Edinburg Note and Edinburg Warrants
as follows:  (i) the conversion price was changed to the Investor's option of an
amount equal to forty cents ($0.40) or an amount equal to a twenty percent (20%)
discount to the then-current market price based on the average closing price for
the twenty (20) days  immediately  preceding the conversion,  with the exception
that the  Conversion  Price  shall  not be lower  than  $0.166;  and (ii)  price
ratchets  were  deleted.  The issuance of the Edinburg  Note was exempt from the
registration requirements of the Securities Act of 1933, as amended, pursuant to
Section 4(2) of the Act for  transactions  not  involving a public  offering and
based on the  fact  that  the  Edinburg  Note was  issued  to  institutional  or
accredited  investors only. The shares of Common Stock underlying the securities
have standard piggy-back registration rights.


                                       32
<PAGE>

On April 1, 2006, the Company issued a Convertible  Promissory Note to Steven J.
Port in the  principal  amount of  $125,000  (the "April Port Note") and related
common stock purchase warrants to purchase, in the aggregate,  312,500 shares of
the Company's  common stock at an exercise  price of $0.75 per share (the "April
Port Warrants"). The April Port Warrants have a term of five years. The original
maturity date of the April Port Note was April 30, 2006 and interest  accrues at
a rate of twenty percent (20%) per annum.  Interest accrues,  but is not due and
payable until the Maturity  Date. The April Port Note  automatically  extends to
the end of each  succeeding  month until such time as the Port provides a 15-day
written  notice  to the  Company  that the  April  Port  Note may no  longer  be
automatically  extended.  The terms of interest will remain the same  throughout
the automatic  extension  periods.  On the Maturity Date, Port has the option of
converting  the  unpaid  principal  and  accrued  interest  into  shares  of the
Company's  common stock at a conversion  price equal to $0.40 or an amount equal
to a twenty percent (20%) discount to the then-current market price based on the
average  closing  price for the  twenty  (20)  days  immediately  preceding  the
conversion; provided, however, that such conversion price shall not be less than
$0.166 per share.  The  issuance of the April Port Note and April Port  Warrants
was exempt from the registration  requirements of the Securities Act of 1933, as
amended,  pursuant to Section 4(2) of the Act for  transactions  not involving a
public  offering  and  based on the fact  that the  securities  were  issued  to
institutional  or  accredited   investors  only.  The  shares  of  Common  Stock
underlying the securities have standard piggy-back registration rights.

On June 1, 2006,  the Company issued a Secured  Promissory  Note to Vicis in the
principal  amount of $50,000 (the "First June Note").  The issuance of the First
June Note was exempt from the registration requirements of the Securities Act of
1933,  as amended,  pursuant  to Section  4(2) of the Act for  transactions  not
involving a public  offering  and based on the fact that the First June Note was
issued to institutional or accredited investors only.

On June 30, 2006, the Company issued a Secured  Promissory  Note to Vicis in the
principal amount of $50,000 (the "Second June Note"). The issuance of the Second
June Note was exempt from the registration requirements of the Securities Act of
1933,  as amended,  pursuant  to Section  4(2) of the Act for  transactions  not
involving a public  offering and based on the fact that the Second June Note was
issued to institutional or accredited investors only.

On August 11, 2006, the Company issued a 10% Secured Convertible Promissory Note
in the  principal  amount of  $1,302,000  (the "Note") to Vicis  pursuant to the
terms of that certain Note Purchase Agreement (the "Purchase Agreement") of even
date therewith.  As consideration for the Note, Vicis (a) delivered  $790,000 in
cash (the "Cash Payment");  (b) surrendered two secured  promissory notes issued
by the Company to Vicis on June 1, 2006, and June 30, 2006,  respectively,  each
in the principal  amount of $50,000  (collectively,  the "June Notes");  and (c)
surrendered a Series AA Convertible  Debenture No. 05-0719 issued by the Company
to  Vicis  on  July  19,  2005,  in  the  principal   amount  of  $412,000  (the
"Debenture"). At any time while the Note remains outstanding,  Vicis may convert
the  outstanding  principal  balance and any accrued but unpaid  interest on the
Note into shares of the Company's common stock, par value $.0005 per share, at a
conversion  price of $.166 per share (the  "Conversion  Shares").  The principal
balance of the Note is due,  in one lump sum  payment,  on August 10,  2007 (the
"Maturity Date"),  unless earlier converted.  Interest on such principal (or any
balance  thereof  outstanding  from time to time)  accrues at an annual  rate of
interest of ten percent  (10%).  The issuance of the Second June Note was exempt
from the  registration  requirements  of the Securities Act of 1933, as amended,
pursuant  to Section  4(2) of the Act for  transactions  not  involving a public
offering  and  based on the fact  that  the  Second  June  Note  was  issued  to
institutional or accredited investors only.


                                       33
<PAGE>

Issuer Purchases of Equity Securities

         The Company did not repurchase any equity  securities during the fiscal
quarter ended June 30, 2006.

Item 3.           Defaults upon Senior Securities.

On November  16,  2005,  the Company  issued a  Promissory  Note for $100,000 to
Laurence Wallace (the "Wallace  Promissory  Note").  The Wallace Promissory Note
accrues  interest at an annual rate of eight percent (8%). The entire  principal
balance  plus any accrued but unpaid  interest  was due on April 17,  2006.  The
Wallace  Promissory  Note is  currently  in default and we are in the process of
negotiating an extension of the Maturity Date, however we may be unsuccessful in
negotiating such an extension.

On November  16,  2005,  the Company  issued a  Promissory  Note for $200,000 to
Carmen Bernstein (the "Bernstein  Promissory  Note").  The Bernstein  Promissory
Note  accrues  interest  at an annual  rate of ten  percent  (10%).  The  entire
principal  balance plus any accrued but unpaid  interest was due on December 14,
2005. As of the date of this filing,  the amounts due  thereunder  have not been
repaid, although it has been extended indefinitely by mutual verbal agreement.

Item 4.           Submission of Matters to a Vote of Security Holders.

Effective  July 25, 2006,  by written  action  completed on August 7, 2006,  the
Company's  shareholders  owning  an  aggregate  of  52.6%  of the  total  shares
outstanding of the Company, voted to approve the Medical Media Television,  Inc.
2006 Equity Incentive Plan with an effective date of May 1, 2006.

Item 5.           Other Information.

None.

                  (Remainder of page left intentionally blank.)


                                       34
<PAGE>

Item 6.           Exhibits.

<TABLE>
<CAPTION>
---------- ----------------------- --------------------------------------------------------------------------------------------
Exh. No.      Date of Document                                       Description of Document
---------- ----------------------- --------------------------------------------------------------------------------------------
<S>        <C>                     <C>
3.0        January 2, 1997         Amended and Restated Articles of Incorporation of Transition Lifestyle Consultants, Inc. (1)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.1        June 12, 2002           Articles of Amendment to the Articles of Incorporation (name change to PetCARE Television
                                   Network, Inc.) (1)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.2        August 2, 2002          Articles of Amendment to the Articles of Incorporation (Series A Convertible Preferred
                                   Stock). (1)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.3        November 12, 2003       Articles of Amendment to the Articles of Incorporation (Series B Convertible Preferred
                                   Stock). (2)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.4        March 30, 2004          Articles of Amendment to the Articles of Incorporation (amend Series A Convertible
                                   Preferred Stock). (2)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.5        June 10, 2004           Articles of Amendment to the Articles of Incorporation (amend Series B Convertible
                                   Preferred Stock). (3)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.6        March 25, 2005          Articles of Amendment to the Articles of Incorporation (increase in authorized stock). (4)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.7        April 21, 2005          Articles of Amendment to the Articles of Incorporation (name change to Medical Media
                                   Television, Inc.). (4)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.8        July 14, 2005           Articles of Amendment to the Articles of Incorporation (Series A Zero Coupon Preferred;
                                   Series B Zero Coupon Preferred). (5)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.9        November 16, 2005       Articles of Merger. (6)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.10       December 22, 2005       Articles of Amendment to the Articles of Incorporation (Series C Zero Coupon Preferred
                                   Stock). (7)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.13       N/A                     Bylaws of PetCARE Television Network, Inc. (1)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.0       November 30, 2005       Amended Note Purchase Agreement from the Company to William H. Quiros for a $1,000,000
                                   loan  (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.1       February 14, 2006       Note Purchase Agreement between the Company and Steven J. Port for a $100,000 loan (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.2       February 15, 2006       Convertible Promissory Note from the Company to Steven J. Port for $100,000 (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.3       February 15, 2006       Common Stock Purchase Warrant from the Company to Steve J. Port (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.4       February 16, 2006       Note Purchase Agreement between the Company and Gilbert B. Ross for a $200,000 loan (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.5       February 16, 2006       Convertible Promissory Note from the Company to Gilbert B. Ross for $200,000 (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.6       February 16, 2006       Common Stock Purchase Warrant from the Company to Gilbert B. Ross (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.7       March 30, 2006          Note Purchase Agreement between the Company and William H. Quiros for a $450,000 loan (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.8       March 31, 2006          Convertible Promissory Note from the Company to William H. Quiros for $450,000 (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.9       March 31, 2006          Amended Note Purchase Agreement between the Company and Elaine G. Edinburg for a $10,000
                                   loan (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.10      April 1, 2006           Note Purchase Agreement between the Company and Steven J. Port for a $125,000 loan (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.11      April 1, 2006           Convertible Promissory Note from the Company to Steven J. Port for $125,000 (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.12      April 1, 2006           Common Stock Purchase Warrant from the Company to Steve J. Port (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.13      April 15, 2006          Note Purchase Agreement between the Company and Softrev Partners, Inc. for a $250,000 loan (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.14      April 16, 2006          Convertible Promissory Note from the Company to Softrev Partners, Inc. for $250,000 (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.15      April 16, 2006          Common Stock Purchase Warrant from the Company to Softrev Partners, Inc. (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.16      May 1, 2006             2006 Medical Media Television, Inc. Equity Incentive Plan (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.17      June 1, 2006            Secured Promissory Note from the Company to Vicis Capital Master Fund for $50,000 (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.18      June 30, 2006           Secured Promissory Note from the Company to Vicis Capital Master Fund for $50,000 (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.19      July 25, 2006           Amended Consulting Agreement between the Company and Saddle Ranch Productions, Inc. (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.20      July 26, 2006           Common Stock Purchase Warrant from the Company to William H. Quiros (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
23.1       August 21, 2006         Consent of Independent Public Accounting Firm (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
</TABLE>


                                       35
<PAGE>

<TABLE>
<S>        <C>                     <C>
---------- ----------------------- --------------------------------------------------------------------------------------------
31.1       August 21, 2006         Certification of Chief Executive Officer of Periodic Report pursuant to Rule 13a-14a and
                                   Rule 14d-14(a). (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
31.2       August 21, 2006         Certification of Principal Financial Officer of Periodic Report pursuant to Rule 13a-14a
                                   and Rule 15d-14(a). (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
32.1       August 21, 2006         Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350. (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
32.2       August 21, 2006         Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350. (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
</TABLE>

-------------------

(1)   Previously  filed  with  Registration  Statement  on Form  SB-2  filed  on
      November 5, 2003.

(2)   Previously  filed with Form 10-KSB for year ended  December 31, 2003 filed
      on March 26, 2004.

(3)   Previously  filed with Form 10-QSB for period ended June 30, 2004 filed on
      August 18, 2004.

(4)   Previously filed with Form 10-QSB for period ended March 31, 2005 filed on
      May 16, 2005.

(5)   Previously  filed with Form 10-QSB for period ended June 30, 2005 filed on
      September 9, 2005.

(6)   Previously  filed with Form  10-QSB for period  ended  September  30, 2005
      filed on November 21, 2005.

(7)   Previously filed with Form SB-2 filed on February 10, 2006.

(*)   Filed herewith.

                  (Remainder of page left intentionally blank.)


                                       36
<PAGE>

                                   SIGNATURES

         In accordance with the requirements of the Exchange Act, the Registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

Dated:   August 21, 2006         MEDICAL MEDIA TELEVISION, INC.

                                  By:      /s/ Philip M. Cohen
                                     -------------------------------------------
                                       Philip M. Cohen, President and Chief
                                       Executive Officer

                                  By:      /s/ Donald R. Mastropietro
                                     -------------------------------------------
                                       Donald R. Mastropietro,  Vice President
                                       Finance and Chief Financial Officer


                                       37